10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

Or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number: 0-50275

BCB Bancorp, Inc.

(Exact name of registrant as specified in its charter)

New Jersey	26-0065262
(State or other jurisdiction of incorporation or organization)	(IRS Employer I.D. No.)
104-110 Avenue C Bayonne, New Jersey	07002
(Address of principal executive offices)	(Zip Code)

(201) 823-0700

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year if changed since last report)

Securities registered pursuant to section 12(b) of the Securities and Exchange Act of 1934:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	BCBP	The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   T   Yes    o   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    x   Yes    o   No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	o	Accelerated Filer	x
Non-Accelerated Filer	o	Smaller Reporting Company	x
		Emerging Growth Company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act).    o  Yes    T  No

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of May 3, 2021, BCB Bancorp, Inc., had 17,121,319 shares of common stock, no par value, outstanding.

‎

BCB BANCORP INC. AND SUBSIDIARIES

INDEX

	Page
PART I. CONSOLIDATED FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
Consolidated Statements of Financial Condition as of March 31, 2021 (unaudited) and December 31, 2020 (unaudited)		1
Consolidated Statements of Income for the three months ended March 31, 2021 and 2020 (unaudited)		2
Consolidated Statements of Comprehensive Income for the three months ended March 31, 2021 and 2020 (unaudited)		3
Consolidated Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021 and 2020 (unaudited)		4
Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020 (unaudited)		5
Notes to Unaudited Consolidated Financial Statements		6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		23
Item 3. Quantitative and Qualitative Disclosures about Market Risk		30
Item 4. Controls and Procedures		30
PART II. OTHER INFORMATION		30
Item 1. Legal Proceedings		30
Item 1A. Risk Factors		31
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		31
Item 3. Defaults Upon Senior Securities		31
Item 4. Mine Safety Disclosures		31
Item 5. Other Information		31
Item 6. Exhibits		32

PART I. CONSOLIDATED FINANCIAL INFORMATION

ITEM I. CONSOLIDATED FINANCIAL STATEMENTS

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Financial Condition

(In thousands, Except Share and Per Share Data, Unaudited)

	March 31,		December 31,
	2021		2020
ASSETS
Cash and amounts due from depository institutions	$	24,796	$	23,201
Interest-earning deposits		272,142		238,028
Total cash and cash equivalents		296,938		261,229
Interest-earning time deposits		735		735
Debt securities available for sale		93,582		99,756
Equity investments		18,278		17,717
Loans held for sale		1,147		3,530
Loans receivable, net of allowance for loan losses
of $35,477 and $33,639 respectively		2,296,434		2,295,021
Federal Home Loan Bank of New York stock, at cost		8,920		11,324
Premises and equipment, net		14,796		15,272
Accrued interest receivable		12,056		12,924
Other real estate owned		414		414
Deferred income taxes		13,239		12,574
Goodwill and other intangibles		5,472		5,488
Operating lease right-of-use assets		14,328		14,988
Bank-owned life insurance ("BOLI")		70,234		61,033
Other assets		5,887		9,011
Total Assets	$	2,852,460	$	2,821,016
LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES
Non-interest -bearing deposits	$	454,061	$	402,100
Interest bearing deposits		1,950,074		1,915,950
Total deposits		2,404,135		2,318,050
FHLB advances		133,298		191,161
Subordinated debentures		37,101		37,042
Operating lease liability		14,589		15,224
Other liabilities		9,883		10,328
Total Liabilities		2,599,006		2,571,805
STOCKHOLDERS' EQUITY
Preferred stock: $0.01 par value, 10,000,000 shares authorized; issued and outstanding 2,596 shares of Series D 4.5%, Series G 6%, and Series H 3.5%, (liquidation value $10,000 per share) noncumulative perpetual preferred stock at March 31, 2021 and December 31, 2020		-		-
Additional paid-in capital preferred stock		25,723		25,723
Common stock: no par value; 40,000,000 shares authorized; issued 19,620,630 and 19,574,858 at March 31, 2021 and December 31, 2020, respectively, outstanding 17,121,319 shares and 17,107,640 shares, at March 31, 2021 and December 31, 2020, respectively		-		-
Additional paid-in capital common stock		192,633		192,276
Retained earnings		62,777		58,335
Accumulated other comprehensive loss		(349)		(205)
Treasury stock, at cost, 2,499,311 and 2,467,218 shares at March 31, 2021 and December 31, 2020, respectively		(27,330)		(26,918)
Total Stockholders' Equity		253,454		249,211
Total Liabilities and Stockholders' Equity	$	2,852,460	$	2,821,016
See accompanying notes to unaudited consolidated financial statements.

‎

1

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Income

(In thousands, Except for Per Share Amounts, Unaudited)

	Three Months Ended March 31,
	2021		2020
Interest and dividend income:
Loans, including fees	$	26,863	$	26,814
Mortgage-backed securities		206		563
Other investment securities		784		8
FHLB stock and other interest earning assets		222		2,034
Total interest income		28,075		29,419
Interest expense:
Deposits:
Demand		1,198		2,208
Savings and club		118		105
Certificates of deposit		1,992		6,432
		3,308		8,745
Borrowings		1,205		1,896
Total interest expense		4,513		10,641
Net interest income		23,562		18,778
Provision for loan losses		1,865		1,500
Net interest income after provision for loan losses		21,697		17,278
Non-interest income:
Fees and service charges		1,111		726
Bank-owned Life Insurance ("BOLI") income		701		-
Gain on sales of loans		274		61
Realized and unrealized loss on equity investments		(196)		(440)
Other		60		336
Total non-interest income		1,950		683
Non-interest expense:
Salaries and employee benefits		6,545		7,389
Occupancy and equipment		2,953		2,824
Data processing and service fees		1,008		938
Professional fees		412		470
Director fees		247		358
Regulatory assessments		376		321
Advertising and promotional		12		61
Other real estate owned, net		4		26
Loss from extinguishment of debt		540		-
Other		1,486		1,977
Total non-interest expense		13,583		14,364
Income before income tax provision		10,064		3,597
Income tax provision		2,947		1,076
Net Income	$	7,117	$	2,521
Preferred stock dividends		283		342
Net Income available to common stockholders	$	6,834	$	2,179
Net Income per common share-basic and diluted
Basic	$	0.40	$	0.12
Diluted	$	0.40	$	0.12
Weighted average number of common shares outstanding
Basic		17,115		17,502
Diluted		17,232		17,551

See accompanying notes to unaudited consolidated financial statements.

2

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income

(In thousands, Unaudited)

	Three Months Ended March 31,
	2021		2020
Net Income	$	7,117	$	2,521
Other comprehensive (loss) income, net of tax:
Unrealized (losses) gains on available-for-sale debt securities:
Unrealized holding (losses) gains arising during the period		(192)		3,309
Tax Effect		48		(820)
Other comprehensive (loss) income		(144)		2,489
Comprehensive income	$	6,973	$	5,010

See accompanying notes to unaudited consolidated financial statements.

3

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statement of Changes in Stockholders’ Equity

(In thousands, Except Share and Per Share Data, Unaudited) 

	Preferred ‎Stock		Common ‎Stock		Additional ‎Paid-In ‎Capital		Retained ‎Earnings		Treasury ‎Stock		Accumulated ‎Other ‎Comprehensive ‎Income ‎(Loss)		Total
Balance at January 1, 2021	$	-	$	-	$	217,999	$	58,335	$	(26,918)	$	(205)	$	249,211
Net income		-		-		-		7,117		-		-		7,117
Other comprehensive loss		-		-		-		-		-		(144)		(144)
Stock-based compensation expense		-		-		135		-		-		-		135
Treasury stock purchases (32,093 shares)		-		-		-		-		(412)		-		(412)
Dividends payable on Series D 4.5%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		-		-		-		(283)		-		-		(283)
Cash dividends on common stock ($0.14 per share declared)		-		-		-		(2,281)		-		-		(2,281)
Dividend reinvestment plan		-		-		111		(111)		-		-		-
Stock purchase plan		-		-		111		-		-		-		111
Balance at March 31, 2021	$	-	$	-	$	218,356	$	62,777	$	(27,330)	$	(349)	$	253,454
	Preferred ‎Stock		Common ‎Stock		Additional ‎Paid-In ‎Capital		Retained ‎Earnings		Treasury ‎Stock		Accumulated ‎Other ‎Comprehensive ‎Income (Loss)		Total
Balance at January 1, 2020	$	-	$	-	$	215,310	$	48,429	$	(22,048)	$	(2,218)	$	239,473
Net income		-		-		-		2,521		-		-		2,521
Other comprehensive income		-		-		-		-		-		2,489		2,489
Cost for Issuance of common stock		-		-		(126)		-		-		-		(126)
Redemption of Series D Preferred Stock		-		-		(140)		-		-		-		(140)
Exercise Stock Option Expense (500 shares)		-		-		5		-		-		-		5
Stock-based compensation expense		-		-		279		-		-		-		279
Treasury stock purchases (127,058 shares)		-		-		-		-		(1,287)		-		(1,287)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		-		-		-		(342)		-		-		(342)
Cash dividends on common stock ($0.14 per share declared)		-		-		-		(2,336)		-		-		(2,336)
Dividend reinvestment plan		-		-		104		(104)		-		-		-
Stock purchase plan		-		-		102		-		-		-		102
Balance at March 31, 2020	$	-	$	-	$	215,534	$	48,168	$	(23,335)	$	271	$	240,638

See accompanying notes to unaudited consolidated financial statements.
‎

4

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands, Unaudited)

	Three Months Ended March 31,
	2021		2020
Cash Flows from Operating Activities :
Net Income	$	7,117	$	2,521
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of premises and equipment		634		734
Amortization and accretion, net		(191)		(579)
Provision for loan losses		1,865		1,500
Deferred income tax benefit		(617)		(293)
Loans originated for sale		(10,074)		(3,868)
Proceeds from sales of loans		12,731		4,008
Gain on sales of loans originated for sale		(274)		(61)
Realized and unrealized loss on equity investments		196		440
Stock-based compensation expense		135		279
BOLI income		(701)		-
Decrease (increase) in interest receivable		868		(618)
Decrease (increase) in other assets		3,124		(186)
Decrease in accrued interest payable		(656)		(516)
Increase in other liabilities		211		2,304
Net Cash Provided by Operating Activities		14,368		5,665
Cash flows from investing activities:
Proceeds from repayments, calls, and maturities on securities available for sale		5,843		7,413
Purchases of securities		(757)		(7,502)
Proceeds from bulk sale of impaired loans		180		-
Net (increase) decrease in loans receivable		(2,891)		13,594
Purchases of BOLI		(8,500)		-
Additions to premises and equipment		(158)		(106)
Redemption (Purchase) of Federal Home Loan Bank of New York stock		2,404		(765)
Net Cash (Used In) Provided by Investing Activities		(3,879)		12,634
Cash flows from financing activities:
Net increase in deposits		86,085		13,658
Proceeds from Federal Home Loan Bank of New York advances		10,000		27,000
Repayments of Federal Home Loan Bank of New York advances		(68,000)		(10,000)
Purchases of treasury stock		(412)		(1,287)
Cash dividends paid on common stock		(2,281)		(2,336)
Cash dividends paid on preferred stock		(283)		(342)
Net proceeds (costs) from issuance of common stock		111		(24)
Net payment on redemption of preferred stock		-		(140)
Exercise of stock options		-		5
Net Cash Provided by Financing Activities		25,220		26,534
Net Increase in Cash and Cash Equivalents		35,709		44,833
Cash and Cash Equivalents-Beginning		261,229		550,353
Cash and Cash Equivalents-Ending	$	296,938	$	595,186
Supplementary Cash Flow Information:
Cash paid during the year for:
Income taxes	$	375	$	279
Interest		5,169		11,157

See accompanying notes to unaudited consolidated financial statements

‎

5

BCB Bancorp Inc. and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates.

These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2020 and the date these consolidated financial statements were issued.

Risks and Uncertainties - We are subject to risks and uncertainties as a result of the ongoing COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict.

The severity of the impact of the ongoing COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers and any government or governmental responses thereto, including legislative or regulatory changes as well as the distribution and effectiveness of COVID-19 vaccines, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Note 2 - Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

Note 3 – Reclassification

Certain amounts as of December 31, 2020 and for the three-month period March 31, 2020 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

Note 4 – Equity Incentive Plans

Equity Incentive Plans

The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank are eligible to participate in the 2011 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options and restricted stock units. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

On February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5-year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4-year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vest over a 2-year period, commencing on the anniversary of the award date.

‎

6

Note 4 – Equity Incentive Plans (Continued)

The following table presents a summary of the status of the Company’s restricted shares as of March 31, 2021 and 2020.

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2021	22,304	$	12.46
Granted	26,700		12.89
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2021	49,004	$	12.70

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2020	81,278	$	11.96
Granted	-		-
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2020	81,278	$	11.96

Expected future expenses relating to the non-vested restricted shares outstanding as of March 31, 2021 was approximately $361,000 over a weighted average period of 3.28 years.

The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2021	1,192,348	$	8.93 - 13.32	$	11.45
Options granted	66,000		12.93		12.93
Options exercised	(7,000)		9.39		9.39
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2021	1,251,348	$	8.93 - 13.32	$	11.54

As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options.

It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $713,000 over a weighted average period of 4.99 years.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2020	1,200,975	$	8.93-13.32	$	11.45
Options granted	-		-		-
Options exercised	(500)		10.55		10.55
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2020	1,200,475	$	8.93-13.32	$	11.45

As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

‎

7

Note 5 – Net Income per Common Share

Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended March 31, 2021 and 2020, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended March 31, 2021 and 2020, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 687, respectively.

The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations:

	For the Three Months Ended March 31,
	2021					2020
		Income	Shares		Per Share		Income	Shares		Per Share
		(Numerator)	(Denominator)		Amount		(Numerator)	(Denominator)		Amount
	(In Thousands, except per share data)
Net income available to common stockholders	$	6,834				$	2,179
Basic earnings per share:
Income available to common stockholders	$	6,834	17,115	$	0.40	$	2,179	17,502	$	0.12
Effect of dilutive securities:
Stock options		-	117				-	49
Diluted earnings per share:
Income available to common stockholders	$	6,834	17,232	$	0.40	$	2,179	17,551	$	0.12

Note 6 - Securities

Equity Securities

Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices.

The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three-months ended March 31, 2021 and 2020:

	For the three months ended March 31,
(In Thousands)	2021		2020
Net losses recognized during the period on equity securities	$	(196)	$	(440)
Less: Net gains recognized during the period on equity securities sold during the period		-		-
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$	(196)	$	(440)

Debt Securities Available for Sale

The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of March 31, 2021 and December 31, 2020:

	March 31, 2021
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,157	$	2	$	72	$	3,087
More than five to ten years		4,429		139		22		4,546
More than ten years		34,995		622		398		35,219
		42,581		763		492		42,852
Corporate Debt securities:
More than five to ten years		32,280		2,077		25		34,332
Municipal obligations:
Less than one year		12,048		-		-		12,048
More than ten years		4,183		167		-		4,350
		16,231		167		-		16,398
Total securities	$	91,092	$	3,007	$	517	$	93,582

‎

8

	December 31, 2020
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,208	$	10	$	67	$	3,151
More than five to ten years		4,799		163		-		4,962
More than ten years		40,531		741		60		41,212
Sub-total:		48,538		914		127		49,325
Corporate Debt securities:
More than five to ten years		32,279		1,719		13		33,985
Sub-total:		32,279		1,719		13		33,985
Municipal obligations:
Due within one year		12,048		-		-		12,048
Due after ten years		4,209		189		-		4,398
Sub-total:		16,257		189		-		16,446
Total Debt Securities Available	$	97,074	$	2,822	$	140	$	99,756

The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows:

	12 Months or Less				More than 12 Months				Total
	Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	Value		Losses		Value		Losses		Value		Losses
	(In Thousands)
March 31, 2021
Residential mortgage-backed securities	$	12,221	$	420	$	1,263	$	72	$	13,484	$	492
Corporate Debt securities		975		25		-		-		975		25
	$	13,196	$	445	$	1,263	$	72	$	14,459	$	517
December 31, 2020
Residential mortgage-backed securities	$	6,126	$	60	$	1,278	$	67	$	7,404	$	127
Corporate Debt Securities		5,487		13		-		-		5,487		13
	$	11,613	$	73	$	1,278	$	67	$	12,891	$	140

Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At March 31, 2021 and December 31, 2020, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depended on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at March 31, 2021 and December 31, 2020, to be temporary.

Note 7 - Loans Receivable and Allowance for Loan Losses

The following tables present the recorded investment in loans receivable as of March 31, 2021 and December 31, 2020 by segment and class:

	March 31, 2021		December 31, 2020
		(In Thousands)
Residential one-to-four family	$	234,375	$	244,369
Commercial and multi-family		1,700,113		1,690,836
Construction		167,224		155,967
Commercial business(1)		177,340		184,357
Home equity(2)		53,360		53,667
Consumer		851		822
		2,333,263		2,330,018
Less:
Deferred loan fees, net		(1,352)		(1,358)
Allowance for loan losses		(35,477)		(33,639)
Sub-total		(36,829)		(34,997)
Total Loans, net	$	2,296,434	$	2,295,021
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.		-

‎

9

Note 7 – Loans Receivable and Allowance for Loan Losses (Continued)

Allowance for Loan Losses

The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion.  

The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:

Lending Policies and Procedures

Personnel responsible for the particular portfolio - relative to experience and ability of staff

Trend for past due, criticized and classified loans

Relevant economic factors

Quality of the loan review system

Value of collateral for collateral dependent loans

The effect of any concentrations of credit and the changes in the level of such concentrations

Other external factors

The methodology includes the segregation of the loan portfolio into two divisions. Loans that are performing and loans that are impaired. Loans which are performing are evaluated by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for qualitative factors referred to above. Impaired loans are loans which are more than 90 days delinquent, troubled debt restructured, or adversely classified. These loans are individually evaluated for loan loss either by current appraisal, or net present value. Management reviews the overall estimate for feasibility and establishes the loan loss provision accordingly. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls.

The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses:

Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower.

Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as economic conditions generally.

Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence.

Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance.

Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default.

Consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness, and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan.

An unallocated component is maintained to cover uncertainties that could affect management’s estimates of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio.

‎

10

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2021	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Charge-offs:		(57)		-		-		-		-		-		-		(57)
Recovery:		27		-		-		-		3		-		-		30
Provisions:		(426)		1,347		25		275		4		-		640		1,865
Ending Balance, March 31, 2021:		2,837		23,119		2,002		6,581		293		-		645		35,477
Ending Balance attributable to loans:
Individually evaluated for impairment		302		381		-		4,601		23		-		-		5,307
Collectively evaluated for impairment		2,535		22,738		2,002		1,980		270		-		645		30,170
Ending Balance, March 31, 2021		2,837		23,119		2,002		6,581		293		-		645		35,477
Loans Receivables:
Individually evaluated for impairment		5,509		44,086		2,787		13,269		1,693		-		-		67,344
Collectively evaluated for impairment		228,866		1,656,027		164,437		164,071		51,667		851		-		2,265,919
Total Gross Loans:	$	234,375	$	1,700,113	$	167,224	$	177,340	$	53,360	$	851	$	-	$	2,333,263
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)			Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2020	$	2,722	$	15,372	$	1,244	$	3,790	$	333	-	$	-	$	273	$	23,734
Charge-offs:		(4)		-		-		-		-			-		-		(4)
Recovery:		-		-		-		302		2			-		-		304
Provisions:		413		(423)		(139)		(135)		290			5		1,489		1,500
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Ending Balance attributable to loans:
Individually evaluated for impairment		354		332		-		2,524		22			-		-		3,232
Collectively evaluated for impairment		2,777		14,617		1,105		1,433		603			5		1,762		22,302
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Loans Receivables:
Individually evaluated for impairment		8,335		9,895		-		3,466		1,326			-		-		23,022
Collectively evaluated for impairment		259,802		1,567,921		101,692		173,680		63,531			1,029		-		2,167,655
Total Gross Loans:	$	268,137	$	1,577,816	$	101,692	$	177,146	$	64,857		$	1,029	$	-	$	2,190,677
_____________________________
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

‎

11

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands):

		Residential		Commercial & Multi-family		Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for credit losses:
Ending Balance attributable to loans:
Individually evaluated for impairment	$	416	$	378	$	-	$	3,640	$	27	$	-	$	-	$	4,461
Collectively evaluated for impairment		2,877		21,394		1,977		2,666		259		-		5		29,178
Ending Balance, December 31, 2020	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Loans Receivables:																-
Individually evaluated for impairment	$	7,281	$	61,854	$	-	$	12,492	$	1,574	$	-	$	-	$	83,201
Collectively evaluated for impairment		237,088		1,628,982		155,967		171,865		52,093		822		-		2,246,817
Total Gross Loans:	$	244,369	$	1,690,836	$	155,967	$	184,357	$	53,667	$	822	$	-	$	2,330,018

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

‎

12

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands):

		Three Months Ended March 31,
		2021		2021		2020		2020
	Average		Interest		Average		Interest
	Recorded		Income		Recorded		Income
	Investment		Recognized		Investment		Recognized
Loans with no related allowance recorded:
Residential one-to-four family	$	3,453	$	34	$	4,656	$	52
Commercial and Multi-family		44,958		282		10,322		99
Construction		1,394		36		-		-
Commercial business(1)		5,171		13		2,013		43
Home equity(2)		1,196		10		848		9
Total Impaired Loans with no allowance recorded:	$	56,172	$	375	$	17,839	$	203
Loans with an allowance recorded:
Residential one-to-four family	$	2,943	$	32	$	3,741	$	41
Commercial and Multi-family		8,013		129		1,241		20
Commercial business(1)		7,710		93		1,690		3
Home equity(2)		438		2		460		4
Consumer		-		-		-		-
Total Impaired Loans with an allowance recorded:	$	19,104	$	256	$	7,132	$	68
Total Impaired Loans:	$	75,276	$	631	$	24,971	$	271

__________

(1)Includes business lines of credit.

(2)Includes home equity lines of credit.

(3)Does not include accretable yield on loans acquired with deteriorated credit.

The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands):

		As of March 31, 2021						As of December 31, 2020
		Recorded		Unpaid Principal		Related		Recorded		Unpaid Principal		Related
		Investment		Balance		Allowance		Investment		Balance		Allowance
Loans with no related allowance recorded:
Residential one-to-four family	$	2,821	$	3,210	$	-	$	4,084	$	4,660	$	-
Commercial and multi-family		32,357		33,761		-		57,558		58,739		-
Construction		2,787		2,787		-		-		-		-
Commercial business(1)		4,498		12,573		-		5,844		17,687		-
Home equity(2)		1,268		1,270		-		1,124		1,126		-
Total Impaired Loans with no related allowance recorded:	$	43,731	$	53,601	$	-	$	68,610	$	82,212	$	-
Loans with an allowance recorded:
Residential one-to-four family	$	2,688	$	2,723	$	302	$	3,197	$	3,252	$	416
Commercial and Multi-family		11,729		15,584		381		4,296		4,501		378
Commercial business(1)		8,771		20,662		4,601		6,648		12,511		3,640
Home equity(2)		425		425		23		450		458		27
Total Impaired Loans with an allowance recorded:	$	23,613	$	39,394	$	5,307	$	14,591	$	20,722	$	4,461
Total Impaired Loans:	$	67,344	$	92,995	$	5,307	$	83,201	$	102,934	$	4,461

__________

(1) Includes business lines of credit.
‎(2) Includes home equity lines of credit.

‎

13

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. Pursuant to the CARES Act, a loan that was current at December 31, 2019 and modified due to the COVID-19 pandemic is not considered a TDR. The types of concessions granted generally include, but are not limited to, interest rate reductions, limitations on the accrued interest charged, term extensions, and deferment of principal. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses.

		At March 31,2021		At December 31, 2020
		(In thousands)
Recorded investment in TDRs:
Accrual status	$	13,474	$	13,760
Non-accrual status		1,074		2,303
Total recorded investment in TDRs	$	14,548	$	16,063

The Company originated one TDR loan totaling $96,532 and one TDR loan totaling $216,102 for the three months ended March 31, 2021 and March 31, 2020, respectively.

For the three months ended March 31, 2021 and March 31, 2020, TDRs, for which there was a payment default within twelve months of restructuring, totaled $127,449 for one loan and $0, respectively.

The following table sets forth the delinquency status of total loans receivable as of March 31, 2021:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Residential one-to-four family	$	936	$	-	$	227	$	1,163	$	233,212	$	234,375	$	-
Commercial and multi-family		13,148		4,410		2,447		20,005		1,680,108		1,700,113		-
Construction		2,787		-		-		2,787		164,437		167,224		-
Commercial business(1)		457		1,153		4,796		6,406		170,934		177,340		-
Home equity(2)		235		39		427		701		52,659		53,360		-
Consumer		-		-		-		-		851		851		-
Total	$	17,563	$	5,602	$	7,897	$	31,062	$	2,302,201	$	2,333,263	$	-

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

The following table sets forth the delinquency status of total loans receivable at December 31, 2020:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Originated loans:
Residential one-to-four family	$	507	$	266	$	664	$	1,437	$	242,932	$	244,369	$	125
Commercial and multi-family		15,910		2,996		1,334		20,240		1,670,596		1,690,836		-
Construction		-		-		-		-		155,967		155,967		-
Commercial business(1)		3,889		904		3,354		8,147		176,210		184,357		133
Home equity(2)		541		12		502		1,055		52,612		53,667		75
Consumer		-		-		-		-		822		822		-
Total	$	20,847	$	4,178	$	5,854	$	30,879	$	2,299,139	$	2,330,018	$	333

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

14

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $7.3 million at March 31, 2021 and $11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $884,000 at March 31, 2021 and $1.1 million at December 31, 2020.

		As of March 31, 2021		As of December 31, 2020
		(In Thousands)		(In Thousands)
Non-Accruing Loans:
Originated loans:
Residential one-to-four family	$	701	$	1,736
Commercial and multi-family		7,962		8,721
Commercial business(1)		5,307		5,383
Home equity(2)		435		556
Total	$	14,405	$	16,396

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $343,000 and $1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $0 and $333,000, respectively, of loans which were more than ninety days past due and still accruing interest.

‎

15

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

Criticized and Classified Assets

Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.”

When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining our regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued.

The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below:

6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency.

7 – Substandard- Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention.

8 – Doubtful- Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status.

9 – Loss- Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery.

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of March 31, 2021 (in thousands). As of March 31, 2021, the Company had no loans with the classified rating of doubtful or loss.

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	232,669	$	724	$	982	$	234,375
Commercial and multi-family		1,622,917		38,464		38,732		1,700,113
Construction		164,437		-		2,787		167,224
Commercial business(1)		162,408		1,998		12,934		177,340
Home equity(2)		52,617		-		743		53,360
Consumer		851		-		-		851
Total Gross Loans	$	2,235,899	$	41,186	$	56,178	$	2,333,263

_________

(1) Includes business lines of credit and PPP loans.

(2) Includes home equity lines of credit.
‎

16

Note 7 - Loans Receivable and Allowance for Loan Losses

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss.

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	241,237	$	1,087	$	2,045	$	244,369
Commercial and multi-family		1,631,838		2,152		56,846		1,690,836
Construction		155,967		-		-		155,967
Commercial business(1)		173,833		1,497		9,027		184,357
Home equity(2)		53,005		-		662		53,667
Consumer		822		-		-		822
Total Gross Loans	$	2,256,702	$	4,736	$	68,580	$	2,330,018

________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

‎

17

Note 8 – Stockholders’ Equity

On December 15, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $2,250,000 for 225 shares.

On September 1, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $5.9 million for 590 shares.

On August 31, 2020, the Company redeemed all 6,465 outstanding shares of its Series F 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $1,000 per share, for a total redemption amount of $6.5 million.

On August 10, 2020, the Company redeemed all 388 outstanding shares of its Series C 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $10,000 per share, for a total redemption amount of $3.9 million.

On July 13, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $3.1 million for 308 shares, effective June 29, 2020.

Note 9 – Bank Owned Life Insurance

The Bank purchased $60 million of bank owned life insurance (“BOLI”) in August, 2020 and an additional $8.5 million in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At March 31, 2021, the Bank had $70.2 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

Note 10 – Goodwill and Other Intangible Assets

The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired.

The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

The Company believes that the fair values of our goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at March 31, 2021.

Amortization expense of the core deposit intangibles was $16,000 and $18,000 for the three months ended March 31, 2021 and 2020 respectively. The unamortized balance of the core deposit intangibles and the amount of goodwill at March 31, 2021 was $219,000 and $5.2 million, respectively. The unamortized balance of the core-deposit intangibles and the amount of goodwill at March 31, 2020 was $281,000 and $5.2 million, respectively.
‎

18

Note 11 – Fair Values of Financial Instruments

Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2: Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity).

An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

The only assets or liabilities that the Company measured at fair value on a recurring basis were as follows. (In thousands):

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021:
Securities
Debt Securities Available for Sale	$	93,582	$	-	$	93,582	$	-
Marketable Equities	$	18,278	$	18,278	$	-	$	-
Total Securities	$	111,860	$	18,278	$	93,582	$	-
As of December 31, 2020:
Securities
Debt Securities Available for Sale	$	99,756	$	-	$	99,756	$	-
Marketable Equities	$	17,717	$	17,717	$	-	$	-
Total Securities	$	117,473	$	17,717	$	99,756	$	-

The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended March 31, 2021 and 2020.

The only assets or liabilities that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands):

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021
Impaired Loans	$	18,306	$	-	$	-	$	18,306
Other real estate owned	$	414	$	-	$	-	$	414
As of December 31, 2020:
Impaired Loans	$	10,130	$	-	$	-	$	10,130
Other real estate owned	$	414	$	-	$	-	$	414

‎

19

Note 11 – Fair Values of Financial Instruments (Continued)

The following tables present additional quantitative information as of March 31, 2021 and December 31, 2020 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands):

Quantitative Information about Level 3 Fair Value Measurements
		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
March 31, 2021:
Impaired Loans	$	18,306	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
December 31, 2020:
Impaired Loans	$	10,130	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable.

(2)Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of March 31, 2021 and December 31, 2020.

Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost)

The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values.

Securities Available for Sale

The fair value of securities available for sale (carried at fair value) are determined by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices.

Equity Securities

The fair values of available-for-sale securities are based on quoted market prices (Level 1).

Loans Held for Sale (Carried at Lower of Cost or Fair Value)

The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value.

Loans Receivable (Carried at Cost)

The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.
‎

20

Note 11 – Fair Values of Financial Instruments (Continued)

Impaired Loans (Generally Carried at Fair Value)

Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at March 31, 2021 and December 31, 2020 consisted of the loan balances of $23.6 million net of a valuation allowance of $5.3 million and $14.6 million net of a valuation of loan allowance of $4.4 million, respectively.

Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value)

Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements.

FHLB of New York Stock (Carried at Cost)

The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities.

Interest Receivable and Payable (Carried at Cost)

The carrying amount of interest receivable and interest payable approximates its fair value.

Deposits (Carried at Cost)

The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

Borrowings and Subordinated Debt (Carried at Cost)

Fair values are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party.

Off-Balance Sheet Financial Instruments (Carried at Cost)

Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table.

‎

21

Note 11 – Fair Values of Financial Instruments (Continued)

The carrying values and estimated fair values of financial instruments were as follows as of March 31, 2021 and December 31, 2020:

		As of March 31, 2021
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	296,938	$	296,938	$	296,938	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		93,582		93,582		-		93,582		-
Equity investments		18,278		18,278		18,278		-		-
Loans held for sale		1,147		1,147		-		1,147		-
Loans receivable, net		2,296,434		2,294,631		-		-		2,294,631
FHLB of New York stock, at cost		8,920		8,920		-		8,920		-
Accrued interest receivable		12,056		12,056		-		12,056		-
Other Real Estate Owned		414		414		-		-		414
Financial liabilities:
Deposits		2,404,135		2,408,469		1,719,149		689,320		-
Borrowings		133,298		131,806		-		131,806		-
Subordinated debentures		37,101		36,686		-		36,686		-
Accrued interest payable		807		807		-		807		-

		As of December 31, 2020
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	261,229	$	261,229	$	261,229	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		99,756		99,756		-		99,756		-
Equity investments		17,717		17,717		17,717		-		-
Loans held for sale		3,530		3,530		-		3,530		-
Loans receivable, net		2,295,021		2,309,118		-		-		2,309,118
FHLB of New York stock, at cost		11,324		11,324		-		11,324		-
Accrued interest receivable		12,924		12,924		-		12,924		-
Other Real Estate Owned		-		-		-		-		-
Financial liabilities:
Deposits		2,318,050		2,323,561		1,627,871		695,690		-
Borrowings		191,161		194,899		-		194,899		-
Subordinated debentures		37,042		37,252		-		37,252		-
Accrued interest payable		1,463		1,463		-		1,463		-

‎

22

Note 12 – Subordinated debt

On July 30, 2018, the Company issued $33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a ten-year term and bear interest at a fixed annual rate of 5.625% for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72% until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital will be used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $523,000 and $911,000 at March 31, 2021 and December 31, 2020, respectively.

The Company also has $4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR and 2.65%.

As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

Note 13 – Lease Obligations

The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 12 years. The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets.

The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months.

The following tables present certain information related to the Company’s leases (in thousands):

		Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Operating lease cost	$	952	$	854
Variable lease cost-operating leases	$	246	$	202
		At March 31, 2021		At December 31, 2020
Supplemental balance sheet information related to leases:
Operating Leases
Operating lease right-of-use assets	$	14,328	$	14,988
Current liabilities	$	3,020	$	2,992
Operating lease liabilities (noncurrent portion)		11,569		12,232
Total operating lease liabilities	$	14,589	$	15,224

The weighted average remaining lease term for operating leases at March 31, 2021 and December 31, 2020 was 6.40 years and 6.57 years, respectively. The weighted average discount rate for operating leases at March 31, 2021 and December 31, 2020 was 2.65 percent and 2.67 percent, respectively.

The following table summarizes the Company’s maturity of lease obligations for operating leases at March 31, 2021 and December 31, 2020 (in thousands):

Maturities of lease liabilities:
		At March 31, 2021		At December 31, 2020
		Operating Leases		Operating Leases
One year or less	$	3,358	$	3,348
Over one year through three years		5,225		5,424
Over three years through five years		3,269		3,459
Over five years		4,065		4,415
Gross Operating Lease Liabilities	$	15,917	$	16,646
Deferred Expenses		(1,328)		(1,422)
Total Operating Lease Liabilities	$	14,589	$	15,224

Note 14 – Subsequent Events

On April 14, 2021, the Board of Directors of the Company declared a cash dividend of $0.14 per share to shareholders of record of its common stock on May 10, 2021 with a payment date of May 24, 2021.

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This report on Form 10-Q contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, or the PSLRA. Such forward-looking statements, in addition to historical information, involve risk and uncertainties, and are based on the beliefs, assumptions and expectations of our management team. Words such as “expects,” “believes,” “should,” “plans,” “anticipates,” “will,” “potential,” “could,” “intend,” “may,” “outlook,” “predict,” “project,” “would,” “estimated,” “assumes,” “likely,” and variation of such similar expressions are intended to identify such forward-looking statements. Forward-looking statements speak only as of the

23

date they are made. Because forward-looking statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those that we anticipated in our forward-looking statements and future results could differ materially from historical performance.

Factors that could cause future results to vary from current management expectations as reflected in our forward-looking statements include, but are not limited to:

unfavorable economic conditions in the United States generally and particularly in our primary market area;

the effects of declines in housing markets and real estate values that may adversely impact the collateral underlying our loans;

increase in unemployment levels and slowdowns in economic growth;

our level of non-performing assets and the costs associated with resolving any problem loans including litigation and other costs;

the impact of changes in interest rates and the credit quality and strength of underlying collateral and the effect of such changes on the market value of our loan and investment securities portfolios;

the credit risk associated with our loan portfolio;

changes in the quality and composition of the Bank’s loan and investment portfolios;

changes in our ability to access cost-effective funding;

deposit flows;

legislative and regulatory changes, including increases in Federal Deposit Insurance Corporation, or FDIC, insurance rates;

monetary and fiscal policies of the federal and state governments;

changes in tax policies, rates and regulations of federal, state and local tax authorities;

inflation;

demands for our loan products;

demand for financial services;

competition;

changes in the securities or secondary mortgage markets;

changes in management’s business strategies;

our ability to enter new markets successfully;

our ability to successfully integrate acquired businesses;

changes in consumer spending;

our ability to retain key employees;

the effects of any reputational, credit, interest rate, market, operational, legal, liquidity, or regulatory risk;

expanded regulatory requirements as a result of the Dodd-Frank Wall Street Reform and Consumer Protection Act, which could adversely affect operating results;

civil unrest in the communities that we serve;

the global spread of the Coronavirus Disease 2019 (“COVID-19”) and the impact that it is having on the United States, in general, and New Jersey and New York, in particular (see Item 1.A. Risk Factors in the Company’s Annual Report on Form 10-K); and 

other factors discussed elsewhere in this report, and in other reports we filed with the SEC, including under “Risk Factors” in Part I, Item 1A of our annual Report on Form 10-K, in Part II, Item 1A of our quarterly reports on Form 10-Q, and our other periodic reports that we file with the SEC.

You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Form 10-Q. We do not assume any obligation to revise forward-looking statements except as may be required by law.

Overview

BCB Bancorp, Inc. is a New Jersey corporation, and is the holding company parent of BCB Community Bank, or the Bank. The Company has not engaged in any significant business activity other than owning all of the outstanding common stock of BCB Community Bank. Our executive office is located at 104-110 Avenue C, Bayonne, New Jersey 07002. At March 31, 2021, we had approximately $2.852 billion in consolidated assets, $2.404 billion in deposits and $253.4 million in consolidated stockholders’ equity.

BCB Community Bank opened for business on November 1, 2000 as Bayonne Community Bank, a New Jersey chartered commercial bank. The Bank changed its name from Bayonne Community Bank to BCB Community Bank in April 2007. At March 31, 2021, the Bank operated through 29 branches in Bayonne, Carteret, Edison, Jersey City, Hoboken, Fairfield, Holmdel, Lyndhurst, Maplewood, Monroe Township, Newark, Parsippany, Plainsboro, River Edge, Rutherford, South Orange, Union, and Woodbridge, New Jersey, as well as three branches in Hicksville and Staten Island, NY, and through executive offices located at 104-110 Avenue C and an administrative office located at 591-595 Avenue C, Bayonne, New Jersey 07002. The Bank’s deposit accounts are insured by the FDIC, and the Bank is a member of the Federal Home Loan Bank System.

We are a community-oriented financial institution. Our business is to offer FDIC-insured deposit products and to invest funds held in deposit accounts at the Bank, together with funds generated from operations, in loans and investment securities. We offer our customers:

loans, including commercial and multi-family real estate loans, one- to four-family mortgage loans, home equity loans, construction loans, consumer loans and commercial business loans. In recent years the primary growth in our loan portfolio has been in loans secured by commercial real estate and multi-family properties;

FDIC-insured deposit products, including savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts; and

retail and commercial banking services including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, mobile banking, gift cards, fraud detection (positive pay), and automated teller services.

Critical Accounting Policies

The preparation of the Consolidated Financial Statements in accordance with U.S. GAAP requires us to make estimates and assumptions affecting the reported amounts of assets, liabilities, revenues and expenses. We regularly evaluate these estimates and assumptions including those used to determine the allowance for loan losses, deferred taxes, fair value measurements, goodwill and other intangible assets. We base our estimates on historical experience and various other factors and assumptions that are believed to be reasonable under the circumstances. These form the basis for making judgments on the carrying value of assets and liabilities that are not readily apparent from other sources. Although our current estimates contemplate current economic conditions and how we expect them to change in the future, for the remainder of 2021, it is reasonably possible that actual conditions may be worse than anticipated in those estimates, which could materially affect our results of operations and financial condition. Actual results may differ from these estimates under different assumptions or conditions.

24

See further discussion of these critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2020 and Note 2, Basis of Presentation, to the unaudited Consolidated Financial Statements. There has been no change in critical accounting policies since the Company’s last annual report on Form 10-K.

COVID-19 Overview

With the global outbreak of COVID-19, the Company remains focused on protecting the health and wellbeing of its employees and the communities in which it operates while assuring the continuity of its business operations. 

The Company activated its dedicated pandemic team that proactively implemented its business continuity plans and has taken a variety of measures to ensure the ongoing availability of services, while taking health and safety measures, including enhanced cleaning and hygiene protocols in all of its facilities and remote work policies, where possible. To date, as a result of these business continuity measures, the Company has not experienced significant disruptions in its operations. 

As of March 31, 2021, the Company had $297 million of cash on hand and available wholesale borrowing capacity of over $800 million.

COVID-19 Response

Operational Initiatives

oThe pandemic response team meets on an as-needed basis and actively monitors guidance released by regulators and banking associations.

oIn-person meetings are closely managed and are held on an as needed basis only.

oMany employees are working remotely, temporarily relocated or are working alternate days to increase social distancing.

oBarriers have been installed in branches and back offices to provide protection.

oBranch and operational offices are cleaned and sanitized biweekly and employees have access to masks, gloves and disinfectant.

oMasks are required for entry and social distancing is strictly enforced.  

oManagement provides updates to employees on a regular basis.

oThe Call Center is open six days a week to assist with customer inquiries.

oBranch offices are open; however, customers have the ability to make an appointment if they choose. The Bank is encouraging customers to utilize the ATM, drive-through and electronic banking services wherever possible.

oThe Bank is working with a local provider to have the vaccine administered at one of the Bank’s locations for its interested employees.

Allowance for Loan Losses (“ALLL”)

oThe Bank increased its loan loss reserves through the addition of $1.9 million in loan loss provisions for the three-month period ending March 31, 2021, as compared to $1.5 million for the same period last year. The Bank considered qualitative factors, such as changes in underwriting policies, current economic conditions, delinquency statistics, the adequacy of the underlying collateral and the financial strength of borrowers in arriving at its loan loss provision. All of these factors are likely to be affected by the COVID-19 pandemic. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls. The impact of COVID-19 is likely to be felt over the next several quarters. Adjustments to the ALLL may be required as the full impact of COVID-19 on the borrowers’ capacity to make payments and the value of the underlying collateral becomes known.

Loan Deferments

oThe banking regulatory agencies, through an Interagency Statement dated April 7, 2020, encouraged financial institutions to work prudently with borrowers who request loan modifications or deferrals as a result of COVID-19. The Bank did so in 2020, but now has no deferred loans within its portfolio.

oThe Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was signed into law on March 27, 2020, and provided over $2.0 trillion in emergency economic relief to individuals and businesses impacted by the COVID-19 pandemic. Under Section 4013 of the CARES Act, loans less than 30 days past due as of December 31, 2019 will be considered current for COVID-19 modifications. A financial institution can then suspend the requirements under GAAP for loan modifications related to COVID-19 that would otherwise be categorized as a TDR, and suspend any determination of a loan modified as a result of COVID-19 as being a TDR, including the requirement to determine impairment for accounting purposes. Most of these loans are accruing interest and the Bank is considering the loans within the overall allowance for loan loss analysis.

oThe Consolidated Appropriations Act of 2021, signed into law on December 27, 2020, extends these provisions through January 1, 2022.

oThe Bank has worked with customers that previously requested loan deferments and entered into COVID-19 modifications. The loan balances for these customers at March 31, 2021 was approximately $86.2 million. The modifications generally provide a short-term, interest-only period. The Bank does not believe that these modified loans will result in losses, so long as the borrowers' representation of cash flows is realized. Borrowers that have requested modifications with less definitive cash flow projections have been denied and are being analyzed as part of the loan stress testing and Allowance for Loan Loss calculation.

Paycheck Protection Program (PPP)

oThe Bank has partnered with The Loan Source, Inc. and recognized $328,000 in brokered referral fees for the second round of PPP loans that they originated in the first quarter of 2021.

IT Changes

oTo protect the well-being of our staff and customers, the Company has set up resources for some employees to work from home. To facilitate the move, we allocated laptop computers to staff and enhanced our ability to access the network offsite. We have taken additional steps to minimize the increased risk of security breaches (including privacy breaches and cyber-attacks), given the increased number of employees working remotely.

Liquidity and Capital Resources

oThe Company was well positioned with adequate levels of cash and liquid assets as of March 31, 2021, as well as wholesale borrowing capacity of over $800 million. At March 31, 2021, the Company’s equity to assets ratio was 8.89 percent and the Bank is considered “well capitalized” under its regulatory requirements. The Company will continue to monitor the effects of COVID-19 in determining future cash dividends and any requirement for additional capital each quarter.

‎

25

Financial Condition

Total assets increased by $31.4 million, or 1.1 percent, to $2.852 billion at March 31, 2021 from $2.821 billion at December 31, 2020. The increase in total assets was mainly related to an increase in total cash and cash equivalents, partly offset by a decrease in investment securities.

Total cash and cash equivalents increased by $35.7 million, or 13.7 percent, to $296.9 million at March 31, 2021 from $261.2 million at December 31, 2020. This increase was mainly related to an increase in deposits, partly offset by net repayments of borrowings.

Loans receivable, net increased by $1.4 million, or 0.1 percent, to $2.296 billion at March 31, 2021 from $2.295 billion at December 31, 2020. Total loan increases for the three months ended March 31, 2021 included increases of $11.2 million in construction loans, $9.3 million in commercial real estate and multi-family loans, $29,000 in consumer loans, partly offset by decreases of $10.0 million in residential one-to-four family loans, $7.0 million in commercial business loans, and $307,000 in home equity loans. The allowance for loan losses increased $1.8 million to $35.5 million, or 246.3 percent of non-accruing loans and 1.52 percent of gross loans, at March 31, 2021 as compared to an allowance for loan losses of $33.6 million, or 205.2 percent of non-accruing loans and 1.44 percent of gross loans, at December 31, 2020.

Total investment securities decreased by $5.6 million, or 4.8 percent, to $111.9 million at March 31, 2021 from $117.5 million at December 31, 2020, representing repayments, calls and maturities, partly offset by purchases of $757,000.

Deposit liabilities increased by $86.1 million, or 3.7 percent, to $2.404 billion at March 31, 2021 from $2.318 billion at December 31, 2020. The increase in deposit liabilities mainly related to the recent payments to individuals under the American Rescue Plan and the second round of PPP payments under the Consolidated Appropriations Act of 2021. Total increases for the three months ended March 31, 2021 included $52.0 million in non-interest-bearing deposit accounts, $20.2 million in money market checking accounts, $13.5 million in savings and club accounts, and $6.3 million in NOW deposit accounts. The increase in deposits was partly offset by decreases of $5.9 million in certificates of deposit, including listing service and brokered deposit accounts. The Company utilizes listing service and brokered certificates of deposit as additional sources of deposit liquidity to fund loan growth. At March 31, 2021, the Company had $17.0 million in listing service deposits and no brokered certificates of deposit.

Debt obligations decreased by $57.8 million, or 25.3 percent, to $170.4 million at March 31, 2021 from $228.2 million at December 31, 2020. The weighted average interest rate of FHLB advances was 1.40 percent at March 31, 2021 and 1.66 percent at December 31, 2020. The fixed interest rate of our subordinated debt balances was 5.625 percent at March 31, 2021 and December 31, 2020. During the three months ended March 31, 2021, the Company opted to extinguish $53.0 million in FHLB advances which held a weighted average rate of 1.83%, and repaid a scheduled maturity of $15.0 million on March 1, 2021, which was at 2.61%. The advances were originally set to mature in 2021 and 2022. The effect of the extinguishment of the debt reduced the weighted average cost of FHLB borrowings by approximately 20 basis points on an annualized basis. The related expense for the extinguishment of this debt is included in noninterest expense.

Stockholders’ equity increased by $4.3 million, or 1.7 percent, to $253.5 million at March 31, 2021 from $249.2 million at December 31, 2020. The increase was primarily attributable to the increase in retained earnings of $4.4 million, or 7.6 percent, to $62.8 million at March 31, 2021 from $58.4 million at December 31, 2020, related to the net effect of net income less dividends paid for the three months ended March 31, 2021.

Net Interest Income Analysis

Net interest income represents the difference between income earned on our interest-earning assets and the expense incurred on our interest-bearing liabilities, and is analyzed and monitored by the Company on a regular basis. The following tables set forth average balance sheets, yields, and costs. The yields include the effect of deferred fees, discounts, and premiums that are amortized or accreted to interest income or expense.

		Three Months Ended March 31,
		2021					2020
		Average Balance		Interest Earned/Paid	Average Yield/Rate (3)			Average Balance		Interest Earned/Paid	Average Yield/Rate (3)
		(Dollars in thousands)
Interest-earning assets:
Loans Receivable	$	2,326,230	$	26,863	4.62%	$		2,185,753	$	26,814	4.91%
Investment Securities		114,461		990	3.46%			92,306		571	2.47%
FHLB Stock and interest earnings assets		264,308		222	0.34%			580,623		2,034	1.40%
Total Interest-earning assets		2,704,999		28,075	4.15%			2,858,682		29,419	4.12%
Non-interest-earning assets		109,987						73,509
Total assets	$	2,814,986				$		2,932,191
Interest-bearing liabilities:
Interest-bearing demand accounts	$	610,893	$	757	0.50%	$		407,339	$	858	0.84%
Money market accounts		317,151		441	0.56%			321,233		1,350	1.68%
Savings accounts		302,741		118	0.16%			259,721		105	0.16%
Certificates of Deposit		682,975		1,992	1.17%			1,120,060		6,432	2.30%
Total interest-bearing deposits		1,913,760		3,308	0.69%			2,108,353		8,745	1.66%
Borrowed funds		205,956		1,205	2.34%			284,830		1,896	2.66%
Total interest-bearing liabilities		2,119,716		4,513	0.85%			2,393,183		10,641	1.78%
Non-interest-bearing liabilities		444,787						299,679
Total liabilities		2,564,503						2,692,862
Stockholders' equity		250,483						239,329
Total liabilities and stockholders' equity	$	2,814,986				$		2,932,191
Net interest income			$	23,562					$	18,778
Net interest rate spread(1)					3.30%						2.34%
Net interest margin(2)					3.48%						2.63%

(1)Net interest rate spread represents the difference between the average yield on average interest-earning assets and the average cost of average interest-bearing liabilities.

(2)Net interest margin represents net interest income divided by average total interest-earning assets.

(3)Annualized.

26

Results of Operations comparison for the Three Months Ended March 31, 2021 and 2020

Net income increased by $4.6 million, or 182.3 percent, to $7.1 million for the three months ended March 31, 2021 from $2.5 million for the three months ended March 31, 2020. The increase in net income was primarily related to a decrease in total interest expense, an increase in total noninterest income, a decrease in total noninterest expense, partly offset by a decrease in interest income, an increase in the provision for loan losses and an increase in the income tax provision for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020.

Net interest income increased by $4.8 million, or 25.5 percent, to $23.6 million for the three months ended March 31, 2021 from $18.8 million for the three months ended March 31, 2020. The increase in net interest income resulted primarily from a $6.1 million decrease in interest expense related to a decrease in the average rate on interest-bearing liabilities of 93 basis points to 0.85 percent for the three months ended March 31, 2021 from 1.78 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of interest-bearing liabilities of $273.5 million, or 11.4 percent, to $2.120 billion for the three months ended March 31, 2021 from $2.393 billion for the three months ended March 31, 2020. Interest income was $1.3 million lower than the prior year, related to a decrease in the average balance of interest-earning assets of $153.7 million, or 5.4 percent, to $2.705 billion for the three months ended March 31, 2021 from $2.859 billion for the three months ended March 31, 2020. The decrease in the average balance of interest-earning assets was partly offset by an increase in the average yield of interest-earning assets of three basis points to 4.15 percent for the three months ended March 31, 2021 from 4.12 percent for the three months ended March 31, 2020. The decrease in the average balance of interest earning assets mainly relates to a decrease in the Company’s level of cash balances for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020, as the Company repaid $130.0 million of FHLB advances and purchased $70.0 million of BOLI.

Interest income on loans receivable increased by $49,000, or 0.2 percent, to $26.9 million for the three months ended March 31, 2021 from $26.8 million for the three months ended March 31, 2020. The increase was primarily attributable to an increase in the average balance of loans receivable of 140.5 million, or 6.4 percent, to $2.326 billion for the three months ended March 31, 2021. as compared to $2.186 billion for the three months ended March 31, 2020. The increase in interest income on loans receivable was partly offset by a decrease in the average yield of loans receivable of 29 basis points to 4.62 percent for the three months ended March 31, 2021 from 4.91 percent for the three months ended March 31, 2020. The increase in the average balance of loans receivable was attributable to the Company’s growth strategy. The decrease in the average yield on loans followed the declining interest rate environment. Interest income on loans also included $211,000 of amortization of purchase credit fair value adjustments for the three months ended March 31, 2021 related to the Company’s April 2018 acquisition of IA Bancorp, Inc. (“IAB”), which added approximately three basis points to the average yield on interest earning assets.

Interest income on securities increased by $419,000 or 73.4 percent, to $990,000 for the three months ended March 31, 2021 from $571,000 for the three months ended March 31, 2020. This increase was primarily due to an increase in the average balance of securities of $22.1 million, or 24.0 percent, to $114.5 million for the three months ended March 31, 2021 from $92.4 million for the three months ended March 31, 2020, as well as an increase in the average yield on securities of 99 basis points to 3.46 percent for the three months ended March 31, 2021 from 2.47 percent for the three months ended March 31, 2020. The increase in the average balance of securities resulted from purchases of new securities, partly offset by faster prepayment speeds, repayments, calls, and maturities, while the increase in the average yield on securities came as a result of the mix of purchases of new securities.

Interest income on other interest-earning assets decreased by $1.8 million, or 89.1 percent to $222,000 for the three months ended March 31, 2021 from $2.0 million for the three months ended March 31, 2020. This decrease was primarily due to a decrease in the average yield on other interest-earning assets of 106 basis points to 0.34 percent for the three months ended March 31, 2021 from 1.40 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of other interest earning assets of $316.3 million, or 54.5 percent, to $264.3 million for the three months ended March 31, 2021 from $580.6 million for the three months ended March 31, 2020. The decrease in the average yield on other interest-earning assets correlated to the decreases in the Fed Funds rate. The decrease in the average balance of other interest-earning assets related to the Company’s current deleveraging strategy and the resulting decrease in cash attributable to loan growth, the purchase of BOLI and the early repayment of certain FHLB borrowings.

Total interest expense decreased by $6.1 million, or 57.6 percent, to $4.5 million for the three months ended March 31, 2021 from $10.6 million for the three months ended March 31, 2020. This decrease resulted primarily from a decrease in the average rate on interest-bearing liabilities of 93 basis points to 0.85 percent for the three months ended March 31, 2021 from 1.78 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of interest-bearing liabilities of $273.5 million, or 11.4 percent, to $2.120 billion for the three months ended March 31, 2021 from $2.393 billion for the three months ended March 31, 2020. The decreases in the average cost of funds and the average balance of interest-bearing liabilities primarily resulted from the declining interest rate environment and the Company’s strategy of a heightened focus on cost of funds and continued deleveraging.

Total deposit interest expense decreased by $5.4 million, or 62.2 percent, to $3.3 million for the three months ended March 31, 2021 from $8.7 million for the three months ended March 31, 2020. This decrease resulted primarily from a decrease in the average rate on deposits of 97 basis points to 0.69 percent for the three months ended March 31, 2021 from 1.66 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of deposits of 194.6 million, or 9.2 percent, to $1.914 billion for the three months ended March 31, 2021 from $2.108 billion for the three months ended March 31, 2020. The decrease in the average rate paid on deposits was primarily due to repricing our deposit base to align with the recent Fed rate reductions and aggressively managing the cost of funds. Approximately $255.4 million of certificates of deposit, with a weighted average rate of 1.37%, will mature in the next six months and is projected to be replaced at significantly lower rates.

Total borrowing interest expense decreased by $691,000, or 36.4 percent, to $1.2 million for the three months ended March 31, 2021 from $1.9 million for the three months ended March 31, 2020. The average balance of borrowings decreased by $78.9 million, or 27.7 percent, to $206.0 million for the three months ended March 31, 2021 from $284.9 million for the three months ended March 31, 2020, as well as a decrease in the average rate on borrowings of 32 basis points to 2.34 percent for the three months ended March 31, 2021 from 2.66 percent for the three months ended March 31, 2020. During the three months ended March 31, 2021, the Company opted to extinguish a $53.0 million FHLB advances which held a weighted average rate of 1.83% and were originally set to mature in 2021 and 2022. The extinguishment of this debt decreased both the average balance of borrowings and the average rate on borrowings for the three months ended March 31, 2021. The effect of the extinguishment of the debt reduced the weighted average cost of FHLB borrowings by approximately 20 basis points on an annualized basis. The related non-recurring expense for the extinguishment of this debt is included in noninterest expense.

Net interest margin was 3.48 percent for the first quarter of 2021, compared to 2.63 percent for the first quarter of 2020. Management has been proactive in managing its cost of funds and has significantly decreased the average cost on total interest-costing liabilities while slightly improving the average yield on interest-earning for the first quarter of 2021 compared to the first quarter of 2020. Despite the ongoing pandemic, the Company was been able to increase its average balance of loans receivable for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020. This increase in the average balance of loans receivable, and the corresponding decrease in cash balances highlight management’s efforts to maintain a strong net interest margin.

The provision for loan losses increased by $365,000, to $1.9 million for the three months ended March 31, 2021 from a provision of $1.5 million for the three months ended March 31, 2020, primarily due to COVID-19 related factors. The provision for loan losses is established based upon management’s review of the Company’s loans and consideration of a variety of factors, including but not limited to: (1) the risk characteristics of the loan portfolio; (2) current economic conditions; (3) actual losses previously experienced; (4) the dynamic activity and fluctuating balance of loans receivable; and (5) the existing level of reserves for loan losses that are probable and estimable. The higher provision for loan losses for the three months ended March 31, 2021 was significantly influenced by the impact of COVID-19 on economic

27

conditions and the increased risk of loan defaults. During the three months ended March 31, 2021, the Company experienced $27,000 in net charge-offs compared to $300,000 in net recoveries for the three months ended March 31, 2020. The Bank had non-accrual loans totaling $14.4 million, or 0.62 percent, of gross loans at March 31, 2021 as compared to $4.4 million, or 0.20 percent, of gross loans at March 31, 2020. The allowance for loan losses was $35.5 million, or 1.52 percent of gross loans at March 31, 2021, and $25.5 million, or 1.17 percent of gross loans at March 31, 2020. The amount of the allowance is based on estimates and the ultimate losses may vary from such estimates. Management assesses the allowance for loan losses on a quarterly basis and makes provisions for loan losses as necessary in order to maintain the adequacy of the allowance. While management uses available information to recognize losses on loans, future loan loss provisions may be necessary based on changes in the aforementioned criteria. In addition, various regulatory agencies, as an integral part of their examination process, periodically review the allowance for loan losses and may require the Company to recognize additional provisions based on their judgment of information available to them at the time of their examination. Management believes that the allowance for loan losses was adequate at March 31, 2021 and March 31, 2020.

Total noninterest income increased by $1.3 million, or 185.5 percent, to $2.0 million for the three months ended March 31, 2021 from $683,000 for the three months ended March 31, 2020. The increase in total noninterest income was mainly related to higher BOLI income of $701,000, higher fees and service charges of $385,000, a lower unrealized loss on equity securities of $244,000, and a higher gain on the sales of loans of $213,000, partly offset by lower other noninterest income of $276,000. The increase in BOLI income relates to an initial purchase of $60.0 million of BOLI product in the third quarter of 2020, and an additional purchase of $8.5 million in the first quarter of 2021. The higher fees and service charges related primarily to $328,000 of referral fees for PPP loans. The decrease in other noninterest income related to the reversal of $295,000 of liabilities previously recorded for IAB acquired loans that paid off in the prior-year quarter The unrealized gains or losses on equity securities, and the decision to sell securities, are based on market conditions.

Total noninterest expense decreased by $781,000, or 5.4 percent, to $13.6 million for the three months ended March 31, 2021 from $14.4 million for the three months ended March 31, 2020.

Salaries and employee benefits expense decreased by $844,000, or 11.4 percent, to $6.5 million for the three months ended March 31, 2021 from $7.4 million for the three months ended March 31, 2020, primarily related to fewer full-time equivalent employees, partly offset by normal compensation increases. The number of full-time equivalent employees for the three months ended March 31, 2021 was 312, as compared with 371 for the same period in 2020.

Occupancy and equipment expense increased by $129,000, or 4.6 percent, to $3.0 million for the three months ended March 31, 2021 from $2.8 million for the three months ended March 31, 2020, largely related to building sanitization costs associated with the COVID-19 pandemic, partly offset by the closure of two of the Company’s branch offices in the fourth quarter of 2020.

Data processing expense increased $70,000, or 7.5 percent, to $1.0 million for the three months ended March 31, 2021 from $938,000 for the three months ended March 31, 2020, primarily related to upgrades to our core system.

Regulatory assessments increased by $55,000 to $376,000 for the three months ended March 31, 2021 from $321,000 for the three months ended March 31, 2020. The increase was primarily related to increases in the FDIC assessment rate and in the FDIC assessment base.

The Company recognized a non-recurring expense of $540,000 for a loss on extinguishment of debt, related to the prepayment of high-cost FHLB borrowings, for the three months ended March 31, 2021.

Other noninterest expense decreased by $491,000, or 24.8 percent, to $1.5 million for the three months ended March 31, 2021 from $2.0 million for the three months ended March 31, 2020. Other noninterest expense consisted of loan expense, business development, office supplies, correspondent bank fees, telephone and communication and miscellaneous fees and expenses. The decrease in the current period was primarily related to a reduction of business development and loan-related expenses, largely attributable to the current pandemic condition.

There were also less significant variances in professional fee expense, advertising expense, other real estate owned expense, and directors’ fees, which netted to a decrease in expenses of $240,000 for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020.

The income tax provision increased by $1.9 million, or 173.9 percent, to $2.9 million for the three months ended March 31, 2021 from $1.0 million for the three months ended March 31, 2020. The increase in the income tax provision was a result of higher taxable income for the three months ended March 31, 2021 as compared with that same period for 2020. The consolidated effective tax rate for the three months ended March 31, 2021 was 29.3 percent compared to 29.9 percent for the three months ended March 31, 2020. The lower rate in the current period related primarily to non-taxable BOLI income and lower non-deductible costs in the current year period.

‎

28

Liquidity and Capital Resources

Liquidity

The overall objective of our liquidity management practices is to ensure the availability of sufficient funds to meet financial commitments and to take advantage of lending and investment opportunities. The Company manages liquidity in order to meet deposit withdrawals on demand or at contractual maturity, to repay borrowings and other obligations as they mature, and to fund loan and investment portfolio opportunities as they arise.

The Company’s primary sources of funds to satisfy its objectives are net growth in deposits (primarily retail), principal and interest payments on loans and investment securities, proceeds from the sale of originated loans and FHLB and other borrowings. The scheduled amortization of loans is a predictable source of funds. Deposit flows and mortgage prepayments are greatly influenced by general interest rates, economic conditions and competition. The Company has other sources of liquidity if a need for additional funds arises, including unsecured overnight lines of credit and other collateralized borrowings from the FHLB and other correspondent banks.

At March 31, 2021 and December 31, 2020, the Company had no overnight borrowings outstanding with the FHLB. The Company utilizes overnight borrowings from time to time to fund short-term liquidity needs. The Company had total FHLB borrowings of $133.3 million at March 31, 2021 and $191.2 million at December 31, 2020. The average rate of FHLB advances was 1.38 percent at March 31, 2021 and 1.66 percent at December 31, 2020. The subordinated debentures have a ten-year term and bear interest at a fixed annual rate of 5.625% for the first five years of the term. From and including August 1, 2023, the interest rate will adjust to a floating rate based on the LIBOR plus 2.72% until redemption or maturity. The Notes are scheduled to mature on August 1, 2028.

As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

The Company had the ability at March 31, 2021 to obtain additional funding from the FHLB of up to $245.7 million, utilizing unencumbered loan collateral. The Company expects to have sufficient funds available to meet current loan commitments in the normal course of business through typical sources of liquidity. Time deposits scheduled to mature in one year or less totaled $586.0 million at March 31, 2021. Based upon historical experience, management estimates that a significant portion of such deposits will remain with the Company.

The Company was well positioned with adequate levels of cash and liquid assets as of March 31, 2021, as well as wholesale borrowing capacity of over $800 million, to cover the decrease in cash flow resulting from COVID-19 loan deferments.

Capital Resources

The Bank is subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet the minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific capital guidelines that involve quantitative measures of the Bank’s assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. The Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk-weightings and other factors.

On September 17, 2019, the FDIC passed a final rule providing qualifying community banking organizations the ability to opt-in to a new community bank leverage ratio (tier 1 capital to average consolidated assets) (“CBLR”) framework, with a minimum requirement of 9% for institutions under $10 billion in assets. Such institutions meeting that requirement may elect to utilize the CBLR in lieu of the general applicable risk-based capital requirements under Basel III. Such institutions that meet the CBLR and certain other qualifying criteria will automatically be deemed to be well-capitalized. The Bank decided to opt-in to the new CBLR, effective for the quarter ended March 31, 2020. Pursuant to the CARES Act, the federal banking regulators in April 2020 issued interim final rules to set the CBLR at 8.0% beginning in the second quarter of 2020 through the end of 2020. Beginning in 2021, the CBLR increased to 8.5% for the calendar year. Community banks will have until January 1, 2022 before the CBLR requirement will return to 9%.

At March 31, 2021 and December 31, 2020, BCB Community Bank exceeded all of its regulatory capital requirements to which it was subject. The following table sets forth the regulatory capital ratios for BCB Community Bank as well as regulatory capital requirements for the periods presented.

		Actual				For Capital Adequacy Purposes				For Well Capitalized Under Prompt Corrective Action
	Dollars in Thousands
As of March 31, 2021:
Bank
Community Bank Leverage Ratio	$	282,348	10.07	%	$	196,268	7.00	%		238,326	8.50	%
As of December 31, 2020:
Bank
Community Bank Leverage Ratio	$	278,229	9.85	%	$	197,169	7.00	%	$	225,336	8.00	%

The Company will continue to monitor the effects of COVID-19 in determining future cash dividends and any requirement for additional capital each quarter. The Company had $412,000 of stock repurchases for the first quarter of 2021.

‎

29

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Management of Market Risk

General. The majority of our assets and liabilities are monetary in nature. Consequently, one of our most significant forms of market risk is interest rate risk. Our assets, consisting primarily of mortgage loans, have longer maturities than our liabilities, consisting primarily of deposits. As a result, a principal part of our business strategy is to manage interest rate risk and reduce the exposure of our net interest income to changes in market interest rates. Accordingly, our Board of Directors has established an Asset/Liability Committee which is responsible for evaluating the interest rate risk inherent in our assets and liabilities, for determining the level of risk that is appropriate given our business strategy, operating environment, capital, liquidity and performance objectives, and for managing this risk consistent with the guidelines approved by the Board of Directors. Senior management monitors the level of interest rate risk on a regular basis and the Asset/Liability Committee, which consists of senior management and outside directors operating under a policy adopted by the Board of Directors, meets quarterly to review our asset/liability policies and interest rate risk position.

The following table presents the Company’s net portfolio value (“NPV”). These calculations were based upon assumptions believed to be fundamentally sound, although they may vary from assumptions utilized by other financial institutions. The information set forth below is based on data that included all financial instruments as of March 31, 2021. Assumptions have been made by the Company relating to interest rates, loan prepayment rates, core deposit duration, and the market values of certain assets and liabilities under the various interest rate scenarios. Actual maturity dates were used for fixed rate loans and certificate accounts. Investment securities were scheduled at either the maturity date or the next scheduled call date based upon management’s judgment of whether the particular security would be called in the current interest rate environment and under assumed interest rate scenarios. Variable rate loans were scheduled as of their next scheduled interest rate repricing date. Additional assumptions made in the preparation of the NPV table include prepayment rates on loans and mortgage-backed securities, core deposits without stated maturity dates were scheduled with an assumed term of 48 months, and money market and non-interest bearing accounts were scheduled with an assumed term of 24 months. The NPV at “PAR” represents the difference between the Company’s estimated value of assets and estimated value of liabilities assuming no change in interest rates. The NPV for a decrease of 200 to 300 basis points has been excluded since it would not be meaningful in the interest rate environment as of March 31, 2021.

The following table sets forth the Company’s NPV as of that date (dollars in thousands).

							NPV as a % of Assets
Change in Calculation	Net Portfolio Value		$ Change from PAR		% Change from PAR		NPV Ratio		Change
+300bp	$	215,473	$	(22,573)	(9.48)	%	8.00	%	(37)	bp
+200bp		227,964		(10,082)	(4.24)		8.30		(7)	bp
+100bp		238,564		518	0.22		8.53		16	bp
PAR		238,046		-	-		8.37		-	bp
-100bp		290,021		51,974	21.83		9.93		156	bp

bp – basis points

The table above indicates that as of March 31, 2021, in the event of a 100 basis point increase in interest rates, we would experience an increase to 8.53% in NPV.

Certain shortcomings are inherent in the methodology used in the above interest rate risk measurement. Modeling changes in NPV require making certain assumptions that may or may not reflect the manner in which actual yields and costs respond to changes in market interest rates. In this regard, the NPV table presented assumes that the composition of our interest-sensitive assets and liabilities existing at the beginning of a period remains constant over the period being measured and assumes that a particular change in interest rates is reflected uniformly across the yield curve regardless of the duration or repricing of specific assets and liabilities. Accordingly, although the NPV table provides an indication of our interest rate risk exposure at a particular point in time, such measurements are not intended to and do not provide a precise forecast of the effect of changes in market interest rates on our net interest income, and will differ from actual results.

ITEM 4.

Controls and Procedures

Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this quarterly report, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms.

There has been no change in the Company’s internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved, from time to time, as plaintiff or defendant in various legal actions arising in the normal course of business. As of March 31, 2021, we were not involved in any material legal proceedings the outcome of which, if determined in a manner adverse to the Company, would have a material adverse effect on our financial condition or results of operations.

‎

30

ITEM 1.A. RISK FACTORS

None.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On December 11, 2020, the Company issued a press release announcing the adoption of a new stock repurchase program, effective December 16, 2020. Under the stock repurchase program, management is authorized to repurchase up to 500,000 shares of the Company’s common stock.

The following table provides certain information related to shares repurchased by the Company during the three months ended March 31, 2021:

Period	Total Number of Shares Purchased		Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 - January 31, 2021	-	$	-	-	-
February 1 - February 29, 2021	-		-	-	-
March 1 - March 31, 2021	32,093		12.79	32,093	467,907
Total	32,093	$	12.79	32,093	467,907

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFTEY DISCLOSURES

Not applicable

ITEM 5. OTHER INFORMATION

None.

‎

31

ITEM 6. EXHIBITS

Exhibit 31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2	Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32	Officers’ Certification filed pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 101.INS	XBRL Instance Document
Exhibit 101.SCH	XBRL Taxonomy Extension Schema
Exhibit 101.CAL	XBRL Taxonomy Extension Calculation LinkBase
Exhibit 101.DEF	XBRL Taxonomy Extension Definition LinkBase
Exhibit 101.LAB	XBRL Taxonomy Extension Label LinkBase
Exhibit 101.PRE	XBRL Taxonomy Extension Presentation LinkBase

‎

32

Signatures

Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

	BCB BANCORP, INC.
Date: May 5, 2021	By:	/s/ Thomas Coughlin
		Thomas Coughlin
		President and Chief Executive Officer (Principal Executive Officer)
Date: May 5, 2021	By:	/s/ Thomas P. Keating
		Thomas P. Keating Senior Vice President and Chief Financial Officer
		(Principal Accounting and Financial Officer)

33

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas Coughlin, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of BCB Bancorp, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and;

d) disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2021	/s/ Thomas Coughlin
	Thomas Coughlin
	President and Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Principal Accounting Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas P. Keating, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of BCB Bancorp, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and;

d) disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2021	/s/ Thomas P. Keating
	Thomas P. Keating Senior Vice President and Chief Financial Officer
	(Principal Accounting and Financial Officer)

EX-32

Exhibit 32

Certification pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Thomas Coughlin, President and Chief Executive Officer and Thomas P. Keating, Senior Vice President and Chief Financial Officer of BCB Bancorp, Inc. (the “Company”) each certify in his capacity as an officer of the Company that he has reviewed the quarterly report of the Company on Form 10-Q for the quarter ended March 31, 2021 and that to the best of his knowledge:

(1) the report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The purpose of this statement is solely to comply with Title 18, Chapter 63, Section 1350 of the United States Code, as amended by Section 906 of the Sarbanes-Oxley Act of 2002.

Date: May 5, 2021	/s/ Thomas Coughlin
	President and Chief Executive Officer (Principal Executive Officer)
Date: May 5, 2021	/s/ Thomas P. Keating
	Senior Vice President and Chief Financial Officer (Principal Accounting and Financial Officer)

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	May 03, 2021
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	0-50275
Entity Registrant Name	BCB Bancorp, Inc.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	26-0065262
Entity Address, Address Line One	104-110 Avenue C
Entity Address, City or Town	Bayonne
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07002
City Area Code	201
Local Phone Number	823-0700
Title of 12(b) Security	Common Stock, no par value
Security Exchange Name	NASDAQ
Trading Symbol	BCBP
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,121,319
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001228454
Amendment Flag	false

XML

Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash and amounts due from depository institutions	$ 24,796	$ 23,201
Interest-earning deposits	272,142	238,028
Total cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net of allowance for loan losses of $35,477 and $33,639 respectively	2,296,434	2,295,021
Federal Home Loan Bank of New York stock, at cost	8,920	11,324
Premises and equipment, net	14,796	15,272
Accrued interest receivable	12,056	12,924
Other real estate owned	414	414
Deferred income taxes	13,239	12,574
Goodwill and other intangibles	5,472	5,488
Operating lease right-of-use assets	14,328	14,988
Bank-owned life insurance ("BOLI")	70,234	61,033
Other assets	5,887	9,011
Total Assets	2,852,460	2,821,016
LIABILITIES
Non-interest-bearing deposits	454,061	402,100
Interest bearing deposits	1,950,074	1,915,950
Total deposits	2,404,135	2,318,050
FHLB advances	133,298	191,161
Subordinated debentures	37,101	37,042
Operating lease liability	14,589	15,224
Other liabilities	9,883	10,328
Total Liabilities	2,599,006	2,571,805
STOCKHOLDERS' EQUITY
Preferred stock: $0.01 par value, 10,000,000 shares authorized, issued and outstanding 2,596 shares of Series D 4.5%, Series G 6%, and Series H 3.5% (liquidation value $10,000 per share) noncumulative perpetual preferred stock at March 31, 2021 and December 31, 2020
Additional paid-in capital preferred stock	25,723	25,723
Common stock: no par value; 40,000,000 shares authorized; issued 19,620,630 and 19,574,858 at March 31, 2021 and December 31, 2020, respectively, outstanding 17,121,319 shares and 17,107,640 shares, at March 31, 2021 and December 31, 2020, respectively
Additional paid-in capital common stock	192,633	192,276
Retained earnings	62,777	58,335
Accumulated other comprehensive loss	(349)	(205)
Treasury stock, at cost, 2,499,311 and 2,467,218 shares at March 31, 2021 and December 31, 2020, respectively	(27,330)	(26,918)
Total Stockholders' Equity	253,454	249,211
Total Liabilities and Stockholders' Equity	$ 2,852,460	$ 2,821,016

XML

Consolidated Statements of Financial Condition (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Loans receivable, allowance for loan losses	$ 35,477	$ 33,639
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	2,596	2,596
Preferred stock, shares outstanding	2,596	2,596
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	19,620,630	19,574,858
Common stock, shares outstanding	17,121,319	17,107,640
Treasury stock, shares	2,499,311	2,467,218
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series G Preferred Stock [Member]
Preferred stock, dividend rate	6.00%	6.00%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000

XML

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Interest and dividend income:
Loans, including fees	$ 26,863	$ 26,814
Mortgage-backed securities	206	563
Other investment securities	784	8
FHLB stock and other interest earning assets	222	2,034
Total interest income	28,075	29,419
Deposits:
Demand	1,198	2,208
Savings and club	118	105
Certificates of deposit	1,992	6,432
Total deposits	3,308	8,745
Borrowings	1,205	1,896
Total interest expense	4,513	10,641
Net interest income	23,562	18,778
Provision for loan losses	1,865	1,500
Net interest income after provision for loan losses	21,697	17,278
Non-interest income:
Fees and service charges	1,111	726
Bank-owned Life Insurance ("BOLI") income	701
Gain on sales of loans	274	61
Realized and unrealized loss on equity investments	(196)	(440)
Other	60	336
Total non-interest income	1,950	683
Non-interest expense:
Salaries and employee benefits	6,545	7,389
Occupancy and equipment	2,953	2,824
Data processing service fees	1,008	938
Professional fees	412	470
Director fees	247	358
Regulatory assessments	376	321
Advertising and promotional	12	61
Other real estate owned, net	4	26
Loss from extinguishment of debt	540
Other	1,486	1,977
Total non-interest expense	13,583	14,364
Income before income tax provision	10,064	3,597
Income tax provision	2,947	1,076
Net Income	7,117	2,521
Preferred stock dividends	283	342
Net Income available to common stockholders	$ 6,834	$ 2,179
Net Income per common share-basic and diluted
Basic	$ 0.40	$ 0.12
Diluted	$ 0.40	$ 0.12
Weighted average number of common shares outstanding
Basic	17,115	17,502
Diluted	17,232	17,551

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Consolidated Statements of Comprehensive Income [Abstract]
Net Income	$ 7,117	$ 2,521
Unrealized (losses) gains on available-for-sale securities:
Unrealized holding (losses) gains arising during the period	(192)	3,309
Tax Effect	48	(820)
Other comprehensive (loss) income	(144)	2,489
Comprehensive income	$ 6,973	$ 5,010

XML

Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance at Dec. 31, 2019	$ 215,310	$ 48,429	$ (22,048)	$ (2,218)	$ 239,473
Net income		2,521			2,521
Other comprehensive (loss) income				2,489	2,489
Cost for Issuance of common stock	(126)				(126)
Redemption of Series D Preferred Stock	(140)				(140)
Exercise Stock Option Expense (500 shares)	5				5
Stock-based compensation expense	279				279
Treasury stock purchases			(1,287)		(1,287)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		(342)			(342)
Cash dividends on common stock ($0.14 per share declared)		(2,336)			(2,336)
Dividend reinvestment plan	104	(104)
Stock purchase plan	102				102
Ending balance at Mar. 31, 2020	215,534	48,168	(23,335)	271	240,638
Beginning balance at Dec. 31, 2020	217,999	58,335	(26,918)	(205)	249,211
Net income		7,117			7,117
Other comprehensive (loss) income				(144)	(144)
Stock-based compensation expense	135				135
Treasury stock purchases			(412)		(412)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock		(283)			(283)
Cash dividends on common stock ($0.14 per share declared)		(2,281)			(2,281)
Dividend reinvestment plan	111	(111)
Stock purchase plan	111				111
Ending balance at Mar. 31, 2021	$ 218,356	$ 62,777	$ (27,330)	$ (349)	$ 253,454

XML

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Exercise of stock options (shares)	7,000	500
Cash dividends on common stock (per share)	$ 0.14	$ 0.14
Treasury stock purchases (shares)	32,093	127,058
Series C Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Series D Preferred Stock [Member]
Preferred stock, dividend rate	4.50%	4.50%	4.50%
Series F Preferred Stock [Member]
Preferred stock, dividend rate		6.00%
Series G Preferred Stock [Member]
Preferred stock, dividend rate	6.00%	6.00%	6.00%
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%	3.50%

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net Income	$ 7,117	$ 2,521
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of premises and equipment	634	734
Amortization and accretion, net	(191)	(579)
Provision for loan losses	1,865	1,500
Deferred income tax benefit	(617)	(293)
Loans originated for sale	(10,074)	(3,868)
Proceeds from sale of loans	12,731	4,008
Gain on sales of loans originated for sale	(274)	(61)
Realized and unrealized loss on equity investments	196	440
Stock-based compensation expense	135	279
BOLI income	(701)
Decrease (increase) in interest receivable	868	(618)
Decrease (increase) in other assets	3,124	(186)
Decrease in accrued interest payable	(656)	(516)
Increase in other liabilities	211	2,304
Net Cash Provided by Operating Activities	14,368	5,665
Cash flows from Investing Activities:
Proceeds from repayments, calls, and maturities on securities available for sale	5,843	7,413
Purchases of securities	(757)	(7,502)
Proceeds from bulk sale of impaired loans	180
Net (increase) decrease in loans receivable	(2,891)	13,594
Purchases of BOLI	(8,500)
Additions to premises and equipment	(158)	(106)
Redemption (Purchase) of Federal Home Loan Bank of New York stock	2,404	(765)
Net Cash (Used In) Provided by Investing Activities	(3,879)	12,634
Cash flows from Financing Activities:
Net increase in deposits	86,085	13,658
Proceeds from Federal Home Loan Bank of New York advances	10,000	27,000
Repayments of Federal Home Loan Bank of New York Advances	(68,000)	(10,000)
Purchases of treasury stock	(412)	(1,287)
Cash dividends paid on common stock	(2,281)	(2,336)
Cash dividends paid on preferred stock	(283)	(342)
Net proceeds (costs) from issuance of common stock	111	(24)
Net payment on redemption of preferred stock		(140)
Exercise of stock options		5
Net Cash Provided by Financing Activities	25,220	26,534
Net Increase in Cash and Cash Equivalents	35,709	44,833
Cash and Cash Equivalents - Beginning	261,229	550,353
Cash and Cash Equivalents - Ending	296,938	595,186
Supplementary Cash Flow Information:
Cash paid during the year for: Income taxes	375	279
Cash paid during the year for: Interest	$ 5,169	$ 11,157

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2021

Basis of Presentation [Abstract]

Basis of Presentation

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates.

These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2020 and the date these consolidated financial statements were issued.

Risks and Uncertainties - We are subject to risks and uncertainties as a result of the ongoing COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict.

The severity of the impact of the ongoing COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers and any government or governmental responses thereto, including legislative or regulatory changes as well as the distribution and effectiveness of COVID-19 vaccines, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

 

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2021

Recent Accounting Pronouncements [Abstract]

Recent Accounting Pronouncements

Note 2 - Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

 

XML

Reclassification

3 Months Ended

Mar. 31, 2021

Reclassification [Abstract]

Reclassification

Note 3 – Reclassification

Certain amounts as of December 31, 2020 and for the three-month period March 31, 2020 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

 

XML

Equity Incentive Plans

3 Months Ended

Mar. 31, 2021

Equity Incentive Plans [Abstract]

Equity Incentive Plans

Note 4 – Equity Incentive Plans

Equity Incentive Plans

The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank are eligible to participate in the 2011 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options and restricted stock units. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

On February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5-year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4-year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vest over a 2-year period, commencing on the anniversary of the award date.

‎

Note 4 – Equity Incentive Plans (Continued)

The following table presents a summary of the status of the Company’s restricted shares as of March 31, 2021 and 2020.

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2021	22,304	$	12.46
Granted	26,700		12.89
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2021	49,004	$	12.70

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2020	81,278	$	11.96
Granted	-		-
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2020	81,278	$	11.96

Expected future expenses relating to the non-vested restricted shares outstanding as of March 31, 2021 was approximately $361,000 over a weighted average period of 3.28 years.

The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2021	1,192,348	$	8.93 - 13.32	$	11.45
Options granted	66,000		12.93		12.93
Options exercised	(7,000)		9.39		9.39
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2021	1,251,348	$	8.93 - 13.32	$	11.54

As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options.

It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $713,000 over a weighted average period of 4.99 years.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2020	1,200,975	$	8.93-13.32	$	11.45
Options granted	-		-		-
Options exercised	(500)		10.55		10.55
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2020	1,200,475	$	8.93-13.32	$	11.45

As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

‎

XML

Net Income per Common Share

3 Months Ended

Mar. 31, 2021

Net Income per Common Share [Abstract]

Net Income per Common Share

Note 5 – Net Income per Common Share

Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended March 31, 2021 and 2020, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended March 31, 2021 and 2020, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 687, respectively.

The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations:

	For the Three Months Ended March 31,
	2021					2020
		Income	Shares		Per Share		Income	Shares		Per Share
		(Numerator)	(Denominator)		Amount		(Numerator)	(Denominator)		Amount
	(In Thousands, except per share data)
Net income available to common stockholders	$	6,834				$	2,179
Basic earnings per share:
Income available to common stockholders	$	6,834	17,115	$	0.40	$	2,179	17,502	$	0.12
Effect of dilutive securities:
Stock options		-	117				-	49
Diluted earnings per share:
Income available to common stockholders	$	6,834	17,232	$	0.40	$	2,179	17,551	$	0.12

 

XML

Securities

3 Months Ended

Mar. 31, 2021

Securities [Abstract]

Securities

Note 6 - Securities

Equity Securities

Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices.

The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three-months ended March 31, 2021 and 2020:

	For the three months ended March 31,
(In Thousands)	2021		2020
Net losses recognized during the period on equity securities	$	(196)	$	(440)
Less: Net gains recognized during the period on equity securities sold during the period		-		-
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$	(196)	$	(440)

Debt Securities Available for Sale

The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of March 31, 2021 and December 31, 2020:

	March 31, 2021
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,157	$	2	$	72	$	3,087
More than five to ten years		4,429		139		22		4,546
More than ten years		34,995		622		398		35,219
		42,581		763		492		42,852
Corporate Debt securities:
More than five to ten years		32,280		2,077		25		34,332
Municipal obligations:
Less than one year		12,048		-		-		12,048
More than ten years		4,183		167		-		4,350
		16,231		167		-		16,398
Total securities	$	91,092	$	3,007	$	517	$	93,582

‎

	December 31, 2020
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,208	$	10	$	67	$	3,151
More than five to ten years		4,799		163		-		4,962
More than ten years		40,531		741		60		41,212
Sub-total:		48,538		914		127		49,325
Corporate Debt securities:
More than five to ten years		32,279		1,719		13		33,985
Sub-total:		32,279		1,719		13		33,985
Municipal obligations:
Due within one year		12,048		-		-		12,048
Due after ten years		4,209		189		-		4,398
Sub-total:		16,257		189		-		16,446
Total Debt Securities Available	$	97,074	$	2,822	$	140	$	99,756

The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows:

	12 Months or Less				More than 12 Months				Total
	Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	Value		Losses		Value		Losses		Value		Losses
	(In Thousands)
March 31, 2021
Residential mortgage-backed securities	$	12,221	$	420	$	1,263	$	72	$	13,484	$	492
Corporate Debt securities		975		25		-		-		975		25
	$	13,196	$	445	$	1,263	$	72	$	14,459	$	517
December 31, 2020
Residential mortgage-backed securities	$	6,126	$	60	$	1,278	$	67	$	7,404	$	127
Corporate Debt Securities		5,487		13		-		-		5,487		13
	$	11,613	$	73	$	1,278	$	67	$	12,891	$	140

Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At March 31, 2021 and December 31, 2020, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depended on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at March 31, 2021 and December 31, 2020, to be temporary.

XML

Loans Receivable and Allowance for Loan Losses

3 Months Ended

Mar. 31, 2021

Loans Receivable and Allowance for Loan Losses [Abstract]

Loans Receivable and Allowance for Loan Losses

Note 7 - Loans Receivable and Allowance for Loan Losses

The following tables present the recorded investment in loans receivable as of March 31, 2021 and December 31, 2020 by segment and class:

	March 31, 2021		December 31, 2020
		(In Thousands)
Residential one-to-four family	$	234,375	$	244,369
Commercial and multi-family		1,700,113		1,690,836
Construction		167,224		155,967
Commercial business(1)		177,340		184,357
Home equity(2)		53,360		53,667
Consumer		851		822
		2,333,263		2,330,018
Less:
Deferred loan fees, net		(1,352)		(1,358)
Allowance for loan losses		(35,477)		(33,639)
Sub-total		(36,829)		(34,997)
Total Loans, net	$	2,296,434	$	2,295,021
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.		-

‎

Note 7 – Loans Receivable and Allowance for Loan Losses (Continued)

Allowance for Loan Losses

The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion.  

The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:

Lending Policies and Procedures

Personnel responsible for the particular portfolio - relative to experience and ability of staff

Trend for past due, criticized and classified loans

Relevant economic factors

Quality of the loan review system

Value of collateral for collateral dependent loans

The effect of any concentrations of credit and the changes in the level of such concentrations

Other external factors

The methodology includes the segregation of the loan portfolio into two divisions. Loans that are performing and loans that are impaired. Loans which are performing are evaluated by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for qualitative factors referred to above. Impaired loans are loans which are more than 90 days delinquent, troubled debt restructured, or adversely classified. These loans are individually evaluated for loan loss either by current appraisal, or net present value. Management reviews the overall estimate for feasibility and establishes the loan loss provision accordingly. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls.

The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses:

Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower.

Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as economic conditions generally.

Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence.

Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance.

Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default.

Consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness, and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan.

An unallocated component is maintained to cover uncertainties that could affect management’s estimates of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2021	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Charge-offs:		(57)		-		-		-		-		-		-		(57)
Recovery:		27		-		-		-		3		-		-		30
Provisions:		(426)		1,347		25		275		4		-		640		1,865
Ending Balance, March 31, 2021:		2,837		23,119		2,002		6,581		293		-		645		35,477
Ending Balance attributable to loans:
Individually evaluated for impairment		302		381		-		4,601		23		-		-		5,307
Collectively evaluated for impairment		2,535		22,738		2,002		1,980		270		-		645		30,170
Ending Balance, March 31, 2021		2,837		23,119		2,002		6,581		293		-		645		35,477
Loans Receivables:
Individually evaluated for impairment		5,509		44,086		2,787		13,269		1,693		-		-		67,344
Collectively evaluated for impairment		228,866		1,656,027		164,437		164,071		51,667		851		-		2,265,919
Total Gross Loans:	$	234,375	$	1,700,113	$	167,224	$	177,340	$	53,360	$	851	$	-	$	2,333,263
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)			Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2020	$	2,722	$	15,372	$	1,244	$	3,790	$	333	-	$	-	$	273	$	23,734
Charge-offs:		(4)		-		-		-		-			-		-		(4)
Recovery:		-		-		-		302		2			-		-		304
Provisions:		413		(423)		(139)		(135)		290			5		1,489		1,500
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Ending Balance attributable to loans:
Individually evaluated for impairment		354		332		-		2,524		22			-		-		3,232
Collectively evaluated for impairment		2,777		14,617		1,105		1,433		603			5		1,762		22,302
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Loans Receivables:
Individually evaluated for impairment		8,335		9,895		-		3,466		1,326			-		-		23,022
Collectively evaluated for impairment		259,802		1,567,921		101,692		173,680		63,531			1,029		-		2,167,655
Total Gross Loans:	$	268,137	$	1,577,816	$	101,692	$	177,146	$	64,857		$	1,029	$	-	$	2,190,677
_____________________________
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands):

		Residential		Commercial & Multi-family		Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for credit losses:
Ending Balance attributable to loans:
Individually evaluated for impairment	$	416	$	378	$	-	$	3,640	$	27	$	-	$	-	$	4,461
Collectively evaluated for impairment		2,877		21,394		1,977		2,666		259		-		5		29,178
Ending Balance, December 31, 2020	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Loans Receivables:																-
Individually evaluated for impairment	$	7,281	$	61,854	$	-	$	12,492	$	1,574	$	-	$	-	$	83,201
Collectively evaluated for impairment		237,088		1,628,982		155,967		171,865		52,093		822		-		2,246,817
Total Gross Loans:	$	244,369	$	1,690,836	$	155,967	$	184,357	$	53,667	$	822	$	-	$	2,330,018

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands):

		Three Months Ended March 31,
		2021		2021		2020		2020
	Average		Interest		Average		Interest
	Recorded		Income		Recorded		Income
	Investment		Recognized		Investment		Recognized
Loans with no related allowance recorded:
Residential one-to-four family	$	3,453	$	34	$	4,656	$	52
Commercial and Multi-family		44,958		282		10,322		99
Construction		1,394		36		-		-
Commercial business(1)		5,171		13		2,013		43
Home equity(2)		1,196		10		848		9
Total Impaired Loans with no allowance recorded:	$	56,172	$	375	$	17,839	$	203
Loans with an allowance recorded:
Residential one-to-four family	$	2,943	$	32	$	3,741	$	41
Commercial and Multi-family		8,013		129		1,241		20
Commercial business(1)		7,710		93		1,690		3
Home equity(2)		438		2		460		4
Consumer		-		-		-		-
Total Impaired Loans with an allowance recorded:	$	19,104	$	256	$	7,132	$	68
Total Impaired Loans:	$	75,276	$	631	$	24,971	$	271

__________

(1)Includes business lines of credit.

(2)Includes home equity lines of credit.

(3)Does not include accretable yield on loans acquired with deteriorated credit.

The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands):

		As of March 31, 2021						As of December 31, 2020
		Recorded		Unpaid Principal		Related		Recorded		Unpaid Principal		Related
		Investment		Balance		Allowance		Investment		Balance		Allowance
Loans with no related allowance recorded:
Residential one-to-four family	$	2,821	$	3,210	$	-	$	4,084	$	4,660	$	-
Commercial and multi-family		32,357		33,761		-		57,558		58,739		-
Construction		2,787		2,787		-		-		-		-
Commercial business(1)		4,498		12,573		-		5,844		17,687		-
Home equity(2)		1,268		1,270		-		1,124		1,126		-
Total Impaired Loans with no related allowance recorded:	$	43,731	$	53,601	$	-	$	68,610	$	82,212	$	-
Loans with an allowance recorded:
Residential one-to-four family	$	2,688	$	2,723	$	302	$	3,197	$	3,252	$	416
Commercial and Multi-family		11,729		15,584		381		4,296		4,501		378
Commercial business(1)		8,771		20,662		4,601		6,648		12,511		3,640
Home equity(2)		425		425		23		450		458		27
Total Impaired Loans with an allowance recorded:	$	23,613	$	39,394	$	5,307	$	14,591	$	20,722	$	4,461
Total Impaired Loans:	$	67,344	$	92,995	$	5,307	$	83,201	$	102,934	$	4,461

__________

(1) Includes business lines of credit.
‎(2) Includes home equity lines of credit.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. Pursuant to the CARES Act, a loan that was current at December 31, 2019 and modified due to the COVID-19 pandemic is not considered a TDR. The types of concessions granted generally include, but are not limited to, interest rate reductions, limitations on the accrued interest charged, term extensions, and deferment of principal. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses.

		At March 31,2021		At December 31, 2020
		(In thousands)
Recorded investment in TDRs:
Accrual status	$	13,474	$	13,760
Non-accrual status		1,074		2,303
Total recorded investment in TDRs	$	14,548	$	16,063

The Company originated one TDR loan totaling $96,532 and one TDR loan totaling $216,102 for the three months ended March 31, 2021 and March 31, 2020, respectively.

For the three months ended March 31, 2021 and March 31, 2020, TDRs, for which there was a payment default within twelve months of restructuring, totaled $127,449 for one loan and $0, respectively.

The following table sets forth the delinquency status of total loans receivable as of March 31, 2021:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Residential one-to-four family	$	936	$	-	$	227	$	1,163	$	233,212	$	234,375	$	-
Commercial and multi-family		13,148		4,410		2,447		20,005		1,680,108		1,700,113		-
Construction		2,787		-		-		2,787		164,437		167,224		-
Commercial business(1)		457		1,153		4,796		6,406		170,934		177,340		-
Home equity(2)		235		39		427		701		52,659		53,360		-
Consumer		-		-		-		-		851		851		-
Total	$	17,563	$	5,602	$	7,897	$	31,062	$	2,302,201	$	2,333,263	$	-

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

The following table sets forth the delinquency status of total loans receivable at December 31, 2020:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Originated loans:
Residential one-to-four family	$	507	$	266	$	664	$	1,437	$	242,932	$	244,369	$	125
Commercial and multi-family		15,910		2,996		1,334		20,240		1,670,596		1,690,836		-
Construction		-		-		-		-		155,967		155,967		-
Commercial business(1)		3,889		904		3,354		8,147		176,210		184,357		133
Home equity(2)		541		12		502		1,055		52,612		53,667		75
Consumer		-		-		-		-		822		822		-
Total	$	20,847	$	4,178	$	5,854	$	30,879	$	2,299,139	$	2,330,018	$	333

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $7.3 million at March 31, 2021 and $11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $884,000 at March 31, 2021 and $1.1 million at December 31, 2020.

		As of March 31, 2021		As of December 31, 2020
		(In Thousands)		(In Thousands)
Non-Accruing Loans:
Originated loans:
Residential one-to-four family	$	701	$	1,736
Commercial and multi-family		7,962		8,721
Commercial business(1)		5,307		5,383
Home equity(2)		435		556
Total	$	14,405	$	16,396

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $343,000 and $1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $0 and $333,000, respectively, of loans which were more than ninety days past due and still accruing interest.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

Criticized and Classified Assets

Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.”

When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining our regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued.

The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below:

6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency.

7 – Substandard- Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention.

8 – Doubtful- Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status.

9 – Loss- Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery.

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of March 31, 2021 (in thousands). As of March 31, 2021, the Company had no loans with the classified rating of doubtful or loss.

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	232,669	$	724	$	982	$	234,375
Commercial and multi-family		1,622,917		38,464		38,732		1,700,113
Construction		164,437		-		2,787		167,224
Commercial business(1)		162,408		1,998		12,934		177,340
Home equity(2)		52,617		-		743		53,360
Consumer		851		-		-		851
Total Gross Loans	$	2,235,899	$	41,186	$	56,178	$	2,333,263

_________

(1) Includes business lines of credit and PPP loans.

(2) Includes home equity lines of credit.
‎

Note 7 - Loans Receivable and Allowance for Loan Losses

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss.

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	241,237	$	1,087	$	2,045	$	244,369
Commercial and multi-family		1,631,838		2,152		56,846		1,690,836
Construction		155,967		-		-		155,967
Commercial business(1)		173,833		1,497		9,027		184,357
Home equity(2)		53,005		-		662		53,667
Consumer		822		-		-		822
Total Gross Loans	$	2,256,702	$	4,736	$	68,580	$	2,330,018

________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

‎

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2021

Stockholders' Equity [Abstract]

Stockholders' Equity

Note 8 – Stockholders’ Equity

On December 15, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $2,250,000 for 225 shares.

On September 1, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $5.9 million for 590 shares.

On August 31, 2020, the Company redeemed all 6,465 outstanding shares of its Series F 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $1,000 per share, for a total redemption amount of $6.5 million.

On August 10, 2020, the Company redeemed all 388 outstanding shares of its Series C 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $10,000 per share, for a total redemption amount of $3.9 million.

On July 13, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $3.1 million for 308 shares, effective June 29, 2020.

XML

Bank Owned Life Insurance

3 Months Ended

Mar. 31, 2021

Bank Owned Life Insurance [Abstract]

Bank Owned Life Insurance

Note 9 – Bank Owned Life Insurance

The Bank purchased $60 million of bank owned life insurance (“BOLI”) in August, 2020 and an additional $8.5 million in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At March 31, 2021, the Bank had $70.2 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2021

Goodwill and Other Intangible Assets [Abstract]

Goodwill and Other Intangible Assets

Note 10 – Goodwill and Other Intangible Assets

The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired.

The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

The Company believes that the fair values of our goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at March 31, 2021.

Amortization expense of the core deposit intangibles was $16,000 and $18,000 for the three months ended March 31, 2021 and 2020 respectively. The unamortized balance of the core deposit intangibles and the amount of goodwill at March 31, 2021 was $219,000 and $5.2 million, respectively. The unamortized balance of the core-deposit intangibles and the amount of goodwill at March 31, 2020 was $281,000 and $5.2 million, respectively.
‎

XML

Fair Values of Financial Instruments

3 Months Ended

Mar. 31, 2021

Fair Values of Financial Instruments [Abstract]

Fair Values of Financial Instruments

Note 11 – Fair Values of Financial Instruments

Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2: Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity).

An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

The only assets or liabilities that the Company measured at fair value on a recurring basis were as follows. (In thousands):

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021:
Securities
Debt Securities Available for Sale	$	93,582	$	-	$	93,582	$	-
Marketable Equities	$	18,278	$	18,278	$	-	$	-
Total Securities	$	111,860	$	18,278	$	93,582	$	-
As of December 31, 2020:
Securities
Debt Securities Available for Sale	$	99,756	$	-	$	99,756	$	-
Marketable Equities	$	17,717	$	17,717	$	-	$	-
Total Securities	$	117,473	$	17,717	$	99,756	$	-

The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended March 31, 2021 and 2020.

The only assets or liabilities that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands):

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021
Impaired Loans	$	18,306	$	-	$	-	$	18,306
Other real estate owned	$	414	$	-	$	-	$	414
As of December 31, 2020:
Impaired Loans	$	10,130	$	-	$	-	$	10,130
Other real estate owned	$	414	$	-	$	-	$	414

‎

Note 11 – Fair Values of Financial Instruments (Continued)

The following tables present additional quantitative information as of March 31, 2021 and December 31, 2020 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands):

Quantitative Information about Level 3 Fair Value Measurements
		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
March 31, 2021:
Impaired Loans	$	18,306	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
December 31, 2020:
Impaired Loans	$	10,130	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable.

(2)Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of March 31, 2021 and December 31, 2020.

Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost)

The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values.

Securities Available for Sale

The fair value of securities available for sale (carried at fair value) are determined by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices.

Equity Securities

The fair values of available-for-sale securities are based on quoted market prices (Level 1).

Loans Held for Sale (Carried at Lower of Cost or Fair Value)

The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value.

Loans Receivable (Carried at Cost)

The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.
‎

Note 11 – Fair Values of Financial Instruments (Continued)

Impaired Loans (Generally Carried at Fair Value)

Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at March 31, 2021 and December 31, 2020 consisted of the loan balances of $23.6 million net of a valuation allowance of $5.3 million and $14.6 million net of a valuation of loan allowance of $4.4 million, respectively.

Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value)

Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements.

FHLB of New York Stock (Carried at Cost)

The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities.

Interest Receivable and Payable (Carried at Cost)

The carrying amount of interest receivable and interest payable approximates its fair value.

Deposits (Carried at Cost)

The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

Borrowings and Subordinated Debt (Carried at Cost)

Fair values are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party.

Off-Balance Sheet Financial Instruments (Carried at Cost)

Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table.

‎

Note 11 – Fair Values of Financial Instruments (Continued)

The carrying values and estimated fair values of financial instruments were as follows as of March 31, 2021 and December 31, 2020:

		As of March 31, 2021
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	296,938	$	296,938	$	296,938	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		93,582		93,582		-		93,582		-
Equity investments		18,278		18,278		18,278		-		-
Loans held for sale		1,147		1,147		-		1,147		-
Loans receivable, net		2,296,434		2,294,631		-		-		2,294,631
FHLB of New York stock, at cost		8,920		8,920		-		8,920		-
Accrued interest receivable		12,056		12,056		-		12,056		-
Other Real Estate Owned		414		414		-		-		414
Financial liabilities:
Deposits		2,404,135		2,408,469		1,719,149		689,320		-
Borrowings		133,298		131,806		-		131,806		-
Subordinated debentures		37,101		36,686		-		36,686		-
Accrued interest payable		807		807		-		807		-

		As of December 31, 2020
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	261,229	$	261,229	$	261,229	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		99,756		99,756		-		99,756		-
Equity investments		17,717		17,717		17,717		-		-
Loans held for sale		3,530		3,530		-		3,530		-
Loans receivable, net		2,295,021		2,309,118		-		-		2,309,118
FHLB of New York stock, at cost		11,324		11,324		-		11,324		-
Accrued interest receivable		12,924		12,924		-		12,924		-
Other Real Estate Owned		-		-		-		-		-
Financial liabilities:
Deposits		2,318,050		2,323,561		1,627,871		695,690		-
Borrowings		191,161		194,899		-		194,899		-
Subordinated debentures		37,042		37,252		-		37,252		-
Accrued interest payable		1,463		1,463		-		1,463		-

‎

XML

Subordinated Debt

3 Months Ended

Mar. 31, 2021

Subordinated Debt [Abstract]

Subordinated Debt

Note 12 – Subordinated debt

On July 30, 2018, the Company issued $33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a ten-year term and bear interest at a fixed annual rate of 5.625% for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72% until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital will be used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $523,000 and $911,000 at March 31, 2021 and December 31, 2020, respectively.

The Company also has $4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR and 2.65%.

As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

 

XML

Lease Obligations

3 Months Ended

Mar. 31, 2021

Lease Obligations [Abstract]

Lease Obligations

Note 13 – Lease Obligations

The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 12 years. The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets.

The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months.

The following tables present certain information related to the Company’s leases (in thousands):

		Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Operating lease cost	$	952	$	854
Variable lease cost-operating leases	$	246	$	202
		At March 31, 2021		At December 31, 2020
Supplemental balance sheet information related to leases:
Operating Leases
Operating lease right-of-use assets	$	14,328	$	14,988
Current liabilities	$	3,020	$	2,992
Operating lease liabilities (noncurrent portion)		11,569		12,232
Total operating lease liabilities	$	14,589	$	15,224

The weighted average remaining lease term for operating leases at March 31, 2021 and December 31, 2020 was 6.40 years and 6.57 years, respectively. The weighted average discount rate for operating leases at March 31, 2021 and December 31, 2020 was 2.65 percent and 2.67 percent, respectively.

The following table summarizes the Company’s maturity of lease obligations for operating leases at March 31, 2021 and December 31, 2020 (in thousands):

Maturities of lease liabilities:
		At March 31, 2021		At December 31, 2020
		Operating Leases		Operating Leases
One year or less	$	3,358	$	3,348
Over one year through three years		5,225		5,424
Over three years through five years		3,269		3,459
Over five years		4,065		4,415
Gross Operating Lease Liabilities	$	15,917	$	16,646
Deferred Expenses		(1,328)		(1,422)
Total Operating Lease Liabilities	$	14,589	$	15,224

 

XML

Subsequent Events

3 Months Ended

Mar. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 14 – Subsequent Events

On April 14, 2021, the Board of Directors of the Company declared a cash dividend of $0.14 per share to shareholders of record of its common stock on May 10, 2021 with a payment date of May 24, 2021.

XML

Equity Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2021

Equity Incentive Plans [Abstract]

Summary of Status of Restricted Shares

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2021	22,304	$	12.46
Granted	26,700		12.89
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2021	49,004	$	12.70

	Number of Shares Awarded		Weighted Average Grant Date Fair Value
Non-vested at January 1, 2020	81,278	$	11.96
Granted	-		-
Vested	-		-
Forfeited	-		-
Non-vested at March 31, 2020	81,278	$	11.96

Summary of Stock Option Activity

The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2021	1,192,348	$	8.93 - 13.32	$	11.45
Options granted	66,000		12.93		12.93
Options exercised	(7,000)		9.39		9.39
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2021	1,251,348	$	8.93 - 13.32	$	11.54

As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options.

It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $713,000 over a weighted average period of 4.99 years.

	Number of Option Shares		Range of Exercise Prices		Weighted Average Exercise Price
Outstanding at January 1, 2020	1,200,975	$	8.93-13.32	$	11.45
Options granted	-		-		-
Options exercised	(500)		10.55		10.55
Options forfeited	-		-		-
Options expired	-		-		-
Outstanding at March 31, 2020	1,200,475	$	8.93-13.32	$	11.45

As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

XML

Net Income per Common Share (Tables)

3 Months Ended

Mar. 31, 2021

Net Income per Common Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	For the Three Months Ended March 31,
	2021					2020
		Income	Shares		Per Share		Income	Shares		Per Share
		(Numerator)	(Denominator)		Amount		(Numerator)	(Denominator)		Amount
	(In Thousands, except per share data)
Net income available to common stockholders	$	6,834				$	2,179
Basic earnings per share:
Income available to common stockholders	$	6,834	17,115	$	0.40	$	2,179	17,502	$	0.12
Effect of dilutive securities:
Stock options		-	117				-	49
Diluted earnings per share:
Income available to common stockholders	$	6,834	17,232	$	0.40	$	2,179	17,551	$	0.12

 

XML

Securities (Tables)

3 Months Ended

Mar. 31, 2021

Securities [Abstract]

Summary of Disaggregated Net Losses on Equity Securities

	For the three months ended March 31,
(In Thousands)	2021		2020
Net losses recognized during the period on equity securities	$	(196)	$	(440)
Less: Net gains recognized during the period on equity securities sold during the period		-		-
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$	(196)	$	(440)

Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale

	March 31, 2021
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,157	$	2	$	72	$	3,087
More than five to ten years		4,429		139		22		4,546
More than ten years		34,995		622		398		35,219
		42,581		763		492		42,852
Corporate Debt securities:
More than five to ten years		32,280		2,077		25		34,332
Municipal obligations:
Less than one year		12,048		-		-		12,048
More than ten years		4,183		167		-		4,350
		16,231		167		-		16,398
Total securities	$	91,092	$	3,007	$	517	$	93,582

‎

	December 31, 2020
			Gross		Gross
	Amortized		Unrealized		Unrealized
	Cost		Gains		Losses		Fair Value
	(In Thousands)
Residential Mortgage-backed securities:
More than one to five years	$	3,208	$	10	$	67	$	3,151
More than five to ten years		4,799		163		-		4,962
More than ten years		40,531		741		60		41,212
Sub-total:		48,538		914		127		49,325
Corporate Debt securities:
More than five to ten years		32,279		1,719		13		33,985
Sub-total:		32,279		1,719		13		33,985
Municipal obligations:
Due within one year		12,048		-		-		12,048
Due after ten years		4,209		189		-		4,398
Sub-total:		16,257		189		-		16,446
Total Debt Securities Available	$	97,074	$	2,822	$	140	$	99,756

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value

	12 Months or Less				More than 12 Months				Total
	Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	Value		Losses		Value		Losses		Value		Losses
	(In Thousands)
March 31, 2021
Residential mortgage-backed securities	$	12,221	$	420	$	1,263	$	72	$	13,484	$	492
Corporate Debt securities		975		25		-		-		975		25
	$	13,196	$	445	$	1,263	$	72	$	14,459	$	517
December 31, 2020
Residential mortgage-backed securities	$	6,126	$	60	$	1,278	$	67	$	7,404	$	127
Corporate Debt Securities		5,487		13		-		-		5,487		13
	$	11,613	$	73	$	1,278	$	67	$	12,891	$	140

XML

Loans Receivable and Allowance for Loan Losses (Tables)

3 Months Ended

Mar. 31, 2021

Loans Receivable and Allowance for Loan Losses [Abstract]

Recorded Investment in Loans Receivable

	March 31, 2021		December 31, 2020
		(In Thousands)
Residential one-to-four family	$	234,375	$	244,369
Commercial and multi-family		1,700,113		1,690,836
Construction		167,224		155,967
Commercial business(1)		177,340		184,357
Home equity(2)		53,360		53,667
Consumer		851		822
		2,333,263		2,330,018
Less:
Deferred loan fees, net		(1,352)		(1,358)
Allowance for loan losses		(35,477)		(33,639)
Sub-total		(36,829)		(34,997)
Total Loans, net	$	2,296,434	$	2,295,021
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.		-

Allowance for Loan Losses

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2021	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Charge-offs:		(57)		-		-		-		-		-		-		(57)
Recovery:		27		-		-		-		3		-		-		30
Provisions:		(426)		1,347		25		275		4		-		640		1,865
Ending Balance, March 31, 2021:		2,837		23,119		2,002		6,581		293		-		645		35,477
Ending Balance attributable to loans:
Individually evaluated for impairment		302		381		-		4,601		23		-		-		5,307
Collectively evaluated for impairment		2,535		22,738		2,002		1,980		270		-		645		30,170
Ending Balance, March 31, 2021		2,837		23,119		2,002		6,581		293		-		645		35,477
Loans Receivables:
Individually evaluated for impairment		5,509		44,086		2,787		13,269		1,693		-		-		67,344
Collectively evaluated for impairment		228,866		1,656,027		164,437		164,071		51,667		851		-		2,265,919
Total Gross Loans:	$	234,375	$	1,700,113	$	167,224	$	177,340	$	53,360	$	851	$	-	$	2,333,263
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands):

	Residential			Commercial & Multi-family	Construction		Commercial Business (1)		Home Equity (2)			Consumer		Unallocated		Total
Allowance for loan losses:
Beginning Balance, January 1, 2020	$	2,722	$	15,372	$	1,244	$	3,790	$	333	-	$	-	$	273	$	23,734
Charge-offs:		(4)		-		-		-		-			-		-		(4)
Recovery:		-		-		-		302		2			-		-		304
Provisions:		413		(423)		(139)		(135)		290			5		1,489		1,500
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Ending Balance attributable to loans:
Individually evaluated for impairment		354		332		-		2,524		22			-		-		3,232
Collectively evaluated for impairment		2,777		14,617		1,105		1,433		603			5		1,762		22,302
Ending Balance March 31, 2020		3,131		14,949		1,105		3,957		625			5		1,762		25,534
Loans Receivables:
Individually evaluated for impairment		8,335		9,895		-		3,466		1,326			-		-		23,022
Collectively evaluated for impairment		259,802		1,567,921		101,692		173,680		63,531			1,029		-		2,167,655
Total Gross Loans:	$	268,137	$	1,577,816	$	101,692	$	177,146	$	64,857		$	1,029	$	-	$	2,190,677
_____________________________
(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

‎

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands):

		Residential		Commercial & Multi-family		Construction		Commercial Business (1)		Home Equity (2)		Consumer		Unallocated		Total
Allowance for credit losses:
Ending Balance attributable to loans:
Individually evaluated for impairment	$	416	$	378	$	-	$	3,640	$	27	$	-	$	-	$	4,461
Collectively evaluated for impairment		2,877		21,394		1,977		2,666		259		-		5		29,178
Ending Balance, December 31, 2020	$	3,293	$	21,772	$	1,977	$	6,306	$	286	$	-	$	5	$	33,639
Loans Receivables:																-
Individually evaluated for impairment	$	7,281	$	61,854	$	-	$	12,492	$	1,574	$	-	$	-	$	83,201
Collectively evaluated for impairment		237,088		1,628,982		155,967		171,865		52,093		822		-		2,246,817
Total Gross Loans:	$	244,369	$	1,690,836	$	155,967	$	184,357	$	53,667	$	822	$	-	$	2,330,018

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Impaired Loans

The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands):

		Three Months Ended March 31,
		2021		2021		2020		2020
	Average		Interest		Average		Interest
	Recorded		Income		Recorded		Income
	Investment		Recognized		Investment		Recognized
Loans with no related allowance recorded:
Residential one-to-four family	$	3,453	$	34	$	4,656	$	52
Commercial and Multi-family		44,958		282		10,322		99
Construction		1,394		36		-		-
Commercial business(1)		5,171		13		2,013		43
Home equity(2)		1,196		10		848		9
Total Impaired Loans with no allowance recorded:	$	56,172	$	375	$	17,839	$	203
Loans with an allowance recorded:
Residential one-to-four family	$	2,943	$	32	$	3,741	$	41
Commercial and Multi-family		8,013		129		1,241		20
Commercial business(1)		7,710		93		1,690		3
Home equity(2)		438		2		460		4
Consumer		-		-		-		-
Total Impaired Loans with an allowance recorded:	$	19,104	$	256	$	7,132	$	68
Total Impaired Loans:	$	75,276	$	631	$	24,971	$	271

__________

(1)Includes business lines of credit.

(2)Includes home equity lines of credit.

(3)Does not include accretable yield on loans acquired with deteriorated credit.

The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands):

		As of March 31, 2021						As of December 31, 2020
		Recorded		Unpaid Principal		Related		Recorded		Unpaid Principal		Related
		Investment		Balance		Allowance		Investment		Balance		Allowance
Loans with no related allowance recorded:
Residential one-to-four family	$	2,821	$	3,210	$	-	$	4,084	$	4,660	$	-
Commercial and multi-family		32,357		33,761		-		57,558		58,739		-
Construction		2,787		2,787		-		-		-		-
Commercial business(1)		4,498		12,573		-		5,844		17,687		-
Home equity(2)		1,268		1,270		-		1,124		1,126		-
Total Impaired Loans with no related allowance recorded:	$	43,731	$	53,601	$	-	$	68,610	$	82,212	$	-
Loans with an allowance recorded:
Residential one-to-four family	$	2,688	$	2,723	$	302	$	3,197	$	3,252	$	416
Commercial and Multi-family		11,729		15,584		381		4,296		4,501		378
Commercial business(1)		8,771		20,662		4,601		6,648		12,511		3,640
Home equity(2)		425		425		23		450		458		27
Total Impaired Loans with an allowance recorded:	$	23,613	$	39,394	$	5,307	$	14,591	$	20,722	$	4,461
Total Impaired Loans:	$	67,344	$	92,995	$	5,307	$	83,201	$	102,934	$	4,461

__________

(1) Includes business lines of credit.
‎(2) Includes home equity lines of credit.

Troubled Debt Restructurings

		At March 31,2021		At December 31, 2020
		(In thousands)
Recorded investment in TDRs:
Accrual status	$	13,474	$	13,760
Non-accrual status		1,074		2,303
Total recorded investment in TDRs	$	14,548	$	16,063

Delinquency Status of Total Loans

The following table sets forth the delinquency status of total loans receivable as of March 31, 2021:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Residential one-to-four family	$	936	$	-	$	227	$	1,163	$	233,212	$	234,375	$	-
Commercial and multi-family		13,148		4,410		2,447		20,005		1,680,108		1,700,113		-
Construction		2,787		-		-		2,787		164,437		167,224		-
Commercial business(1)		457		1,153		4,796		6,406		170,934		177,340		-
Home equity(2)		235		39		427		701		52,659		53,360		-
Consumer		-		-		-		-		851		851		-
Total	$	17,563	$	5,602	$	7,897	$	31,062	$	2,302,201	$	2,333,263	$	-

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

The following table sets forth the delinquency status of total loans receivable at December 31, 2020:

													Loans Receivable
	30-59 Days		60-90 Days		Greater Than		Total Past				Total Loans		>90 Days
	Past Due		Past Due		90 Days		Due		Current		Receivable		and Accruing
		(In Thousands)
Originated loans:
Residential one-to-four family	$	507	$	266	$	664	$	1,437	$	242,932	$	244,369	$	125
Commercial and multi-family		15,910		2,996		1,334		20,240		1,670,596		1,690,836		-
Construction		-		-		-		-		155,967		155,967		-
Commercial business(1)		3,889		904		3,354		8,147		176,210		184,357		133
Home equity(2)		541		12		502		1,055		52,612		53,667		75
Consumer		-		-		-		-		822		822		-
Total	$	20,847	$	4,178	$	5,854	$	30,879	$	2,299,139	$	2,330,018	$	333

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $7.3 million at March 31, 2021 and $11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $884,000 at March 31, 2021 and $1.1 million at December 31, 2020.

		As of March 31, 2021		As of December 31, 2020
		(In Thousands)		(In Thousands)
Non-Accruing Loans:
Originated loans:
Residential one-to-four family	$	701	$	1,736
Commercial and multi-family		7,962		8,721
Commercial business(1)		5,307		5,383
Home equity(2)		435		556
Total	$	14,405	$	16,396

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $343,000 and $1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $0 and $333,000, respectively, of loans which were more than ninety days past due and still accruing interest.

Loan Portfolio by Pass Rating

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	232,669	$	724	$	982	$	234,375
Commercial and multi-family		1,622,917		38,464		38,732		1,700,113
Construction		164,437		-		2,787		167,224
Commercial business(1)		162,408		1,998		12,934		177,340
Home equity(2)		52,617		-		743		53,360
Consumer		851		-		-		851
Total Gross Loans	$	2,235,899	$	41,186	$	56,178	$	2,333,263

_________

(1) Includes business lines of credit and PPP loans.

(2) Includes home equity lines of credit.
‎

Note 7 - Loans Receivable and Allowance for Loan Losses

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss.

	Pass		Special Mention		Substandard		Total
Residential one-to-four family	$	241,237	$	1,087	$	2,045	$	244,369
Commercial and multi-family		1,631,838		2,152		56,846		1,690,836
Construction		155,967		-		-		155,967
Commercial business(1)		173,833		1,497		9,027		184,357
Home equity(2)		53,005		-		662		53,667
Consumer		822		-		-		822
Total Gross Loans	$	2,256,702	$	4,736	$	68,580	$	2,330,018

________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

XML

Fair Values of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2021

Fair Values of Financial Instruments [Abstract]

Fair Value Measurements, Recurring

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021:
Securities
Debt Securities Available for Sale	$	93,582	$	-	$	93,582	$	-
Marketable Equities	$	18,278	$	18,278	$	-	$	-
Total Securities	$	111,860	$	18,278	$	93,582	$	-
As of December 31, 2020:
Securities
Debt Securities Available for Sale	$	99,756	$	-	$	99,756	$	-
Marketable Equities	$	17,717	$	17,717	$	-	$	-
Total Securities	$	117,473	$	17,717	$	99,756	$	-

Fair Value Measurements, Nonrecurring

			(Level 1)		(Level 2)
			Quoted Prices in		Significant		(Level 3)
			Active Markets		Other		Significant
			for Identical		Observable		Unobservable
Description	Total		Assets		Inputs		Inputs
As of March 31, 2021
Impaired Loans	$	18,306	$	-	$	-	$	18,306
Other real estate owned	$	414	$	-	$	-	$	414
As of December 31, 2020:
Impaired Loans	$	10,130	$	-	$	-	$	10,130
Other real estate owned	$	414	$	-	$	-	$	414

Quantitative Information about Level 3 Fair Value Measurements

Quantitative Information about Level 3 Fair Value Measurements
		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
March 31, 2021:
Impaired Loans	$	18,306	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

		Fair Value	Valuation	Unobservable
		Estimate	Techniques	Input	Range
December 31, 2020:
Impaired Loans	$	10,130	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%
Other real estate owned	$	414	Appraisal of collateral (1)	Appraisal adjustments (2)	0%-10%

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable.

(2)Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

Carrying Values and Estimated Fair Values of Financial Instruments

		As of March 31, 2021
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	296,938	$	296,938	$	296,938	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		93,582		93,582		-		93,582		-
Equity investments		18,278		18,278		18,278		-		-
Loans held for sale		1,147		1,147		-		1,147		-
Loans receivable, net		2,296,434		2,294,631		-		-		2,294,631
FHLB of New York stock, at cost		8,920		8,920		-		8,920		-
Accrued interest receivable		12,056		12,056		-		12,056		-
Other Real Estate Owned		414		414		-		-		414
Financial liabilities:
Deposits		2,404,135		2,408,469		1,719,149		689,320		-
Borrowings		133,298		131,806		-		131,806		-
Subordinated debentures		37,101		36,686		-		36,686		-
Accrued interest payable		807		807		-		807		-

		As of December 31, 2020
					Quoted Prices in Active		Significant		Significant
	Carrying				Markets for Identical Assets		Other Observable Inputs		Unobservable Inputs
	Value		Fair Value		(Level 1)		(Level 2)		(Level 3)
	(In Thousands)
Financial assets:
Cash and cash equivalents	$	261,229	$	261,229	$	261,229	$	-	$	-
Interest-earning time deposits		735		735		-		735		-
Debt securities available for sale		99,756		99,756		-		99,756		-
Equity investments		17,717		17,717		17,717		-		-
Loans held for sale		3,530		3,530		-		3,530		-
Loans receivable, net		2,295,021		2,309,118		-		-		2,309,118
FHLB of New York stock, at cost		11,324		11,324		-		11,324		-
Accrued interest receivable		12,924		12,924		-		12,924		-
Other Real Estate Owned		-		-		-		-		-
Financial liabilities:
Deposits		2,318,050		2,323,561		1,627,871		695,690		-
Borrowings		191,161		194,899		-		194,899		-
Subordinated debentures		37,042		37,252		-		37,252		-
Accrued interest payable		1,463		1,463		-		1,463		-

XML

Lease Obligations (Tables)

3 Months Ended

Mar. 31, 2021

Lease Obligations [Abstract]

Schedule of Lease Information

		Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Operating lease cost	$	952	$	854
Variable lease cost-operating leases	$	246	$	202
		At March 31, 2021		At December 31, 2020
Supplemental balance sheet information related to leases:
Operating Leases
Operating lease right-of-use assets	$	14,328	$	14,988
Current liabilities	$	3,020	$	2,992
Operating lease liabilities (noncurrent portion)		11,569		12,232
Total operating lease liabilities	$	14,589	$	15,224

Summary of Maturity of Lease Obligations for Operating Leases

Maturities of lease liabilities:
		At March 31, 2021		At December 31, 2020
		Operating Leases		Operating Leases
One year or less	$	3,358	$	3,348
Over one year through three years		5,225		5,424
Over three years through five years		3,269		3,459
Over five years		4,065		4,415
Gross Operating Lease Liabilities	$	15,917	$	16,646
Deferred Expenses		(1,328)		(1,422)
Total Operating Lease Liabilities	$	14,589	$	15,224

XML

Equity Incentive Plans (Narrative) (Details) - USD ($)			3 Months Ended
	Feb. 19, 2021	Feb. 10, 2021	Mar. 31, 2021	Mar. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Options granted			66,000
Shares underlying unexercised options			426,812
Expected future compensation expense, unexercised options			$ 713,000
Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future compensation expense, weighted average period for recognition			4 years 11 months 26 days
Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future expenses relating to non-vested restricted shares			$ 361,000
Expected future compensation expense, weighted average period for recognition			3 years 3 months 10 days
2018 Equity Incentive Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance			1,000,000
2011 Stock Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance			900,000
Directors [Member] | 2018 Equity Incentive Plan [Member] | Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted		66,000
Vesting period		5 years
Directors [Member] | 2018 Equity Incentive Plan [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued	300	26,400
Vesting period	2 years	4 years

XML

Equity Incentive Plans (Summary of Status of Restricted Shares) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Equity Incentive Plans [Abstract]
Number of Shares Awarded, Non-vested at beginning of period	22,304	81,278
Number of Shares Awarded, Granted	26,700
Number of Shares Awarded, Vested
Number of Shares Awarded, Forfeited
Number of Shares Awarded, Non-vested at end of period	49,004	81,278
Weighted Average Grant Date Fair Value, Non-vested at beginning of period	$ 12.46	$ 11.96
Weighted Average Grant Date Fair Value, Granted	12.89
Weighted Average Grant Date Fair Value, Vested
Weighted Average Grant Date Fair Value, Forfeited
Weighted Average Grant Date Fair Value, Non-vested at end of period	$ 12.70	$ 11.96

XML

Equity Incentive Plans (Summary of Stock Option Activity) (Details) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Equity Incentive Plans [Abstract]
Outstanding, Beginning Balance - Number of Options	1,192,348	1,200,975	1,200,975
Options Granted - Number of Options	66,000
Options Exercised - Number of Options	(7,000)	(500)
Options Forfeited - Number of Options
Options Expired - Number of Options
Outstanding, Ending Balance - Number of Options	1,251,348	1,200,475	1,192,348	1,200,975
Outstanding, Range of Exercise Price, Lower Range Limit (per share)	$ 8.93	$ 8.93	$ 8.93	$ 8.93
Outstanding, Range of Exercise Price, Upper Range Limit (per share)	13.32	13.32	13.32	13.32
Options Granted, Exercise Price	12.93
Options Exercised - Exercise Price	9.39	10.55
Outstanding Number of Options, Beginning Balance - Weighted Average Exercise Price	11.45	11.45	11.45
Number of Options Granted - Weighted Average Exercise Price	12.93
Number of Options, Exercised - Weighted Average Exercise Price	9.39	10.55
Outstanding Number of Options, Ending Balance - Weighted Average Exercise Price	$ 11.54	$ 11.45	$ 11.45	$ 11.45
Exercisable - Number of Options	824,536	515,800

XML

Net Income per Common Share (Narrative) (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net Income per Common Share [Abstract]
Anti-dilutive outstanding options	0	687

XML

Net Income Per Common Share (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net Income per Common Share [Abstract]
Net income available to common stockholders	$ 7,117	$ 2,521
Basic earnings per share- Income available to Common stockholders	6,834	2,179
Diluted earnings per share- Income available to Common stockholders	$ 6,834	$ 2,179
Basic earnings per share- Income available to Common stockholders, Shares	17,115	17,502
Effect of dilutive securities: Stock options: Shares	117	49
Diluted earnings per share- Income available to Common stockholders, Shares	17,232	17,551
Basic earnings per share- Income available to Common stockholders, Per share amount	$ 0.40	$ 0.12
Diluted earnings per share - Income available to Common stockholders, Per share amount	$ 0.40	$ 0.12

XML

Securities (Summary of Disaggregated Net Losses on Equity Securities) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Securities [Abstract]
Net losses recognized during the period on equity securities	$ (196)	$ (440)
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$ (196)	$ (440)

XML

Securities (Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, Amortized Cost	$ 91,092	$ 97,074
Debt securities: Gross Unrealized Gains	3,007	2,822
Debt securities: Gross Unrealized Losses	517	140
Debt securities: Fair Value	93,582	99,756
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than one to five years, Amortized Cost	3,157	3,208
Debt securities, More than five to ten years, Amortized Cost	4,429	4,799
Debt securities, More than ten years, Amortized Cost	34,995	40,531
Debt Securities, Amortized Cost	42,581	48,538
Debt securities, More than one to five years, Gross Unrealized Gains	2	10
Debt securities: More than five to ten years, Gross Unrealized Gains	139	163
Debt securities, More than ten years, Gross Unrealized Gains	622	741
Debt securities: Gross Unrealized Gains	763	914
Debt securities: More than one to five years, Gross Unrealized Losses	72	67
Debt securities: More than five to ten years, Gross Unrealized Losses	22
Debt securities: More than ten years, Gross Unrealized Losses	398	60
Debt securities: Gross Unrealized Losses	492	127
Debt securities: More than one to five years, Fair Value	3,087	3,151
Debt securities: More than five to ten years, Fair Value	4,546	4,962
Debt securities: More than ten years, Fair Value	35,219	41,212
Debt securities: Fair Value	42,852	49,325
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than five to ten years, Amortized Cost	32,280	32,279
Debt Securities, Amortized Cost		32,279
Debt securities: More than five to ten years, Gross Unrealized Gains	2,077	1,719
Debt securities: Gross Unrealized Gains		1,719
Debt securities: More than five to ten years, Gross Unrealized Losses	25	13
Debt securities: Gross Unrealized Losses		13
Debt securities: More than five to ten years, Fair Value	34,332	33,985
Debt securities: Fair Value		33,985
Municipal Obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, Within one year, Amortized Cost	12,048	12,048
Debt securities, More than ten years, Amortized Cost	4,183	4,209
Debt Securities, Amortized Cost	16,231	16,257
Debt securities, More than ten years, Gross Unrealized Gains	167	189
Debt securities: Gross Unrealized Gains	167	189
Debt securities: Less than one year, Fair Value	12,048	12,048
Debt securities: More than ten years, Fair Value	4,350	4,398
Debt securities: Fair Value	$ 16,398	$ 16,446

XML

Securities (Available-for-Sale Securities, Continuous Unrealized Loss Position, Fair Value ) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	$ 13,196	$ 11,613
Debt Securities, More than 12 Months - Fair Value	1,263	1,278
Debt Securities - Total Fair Value	14,459	12,891
Debt Securities, 12 Months or Less - Unrealized Losses	445	73
Debt Securities, More than 12 Months - Unrealized Losses	72	67
Debt Securities - Total Unrealized Losses	517	140
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	12,221	6,126
Debt Securities, More than 12 Months - Fair Value	1,263	1,278
Debt Securities - Total Fair Value	13,484	7,404
Debt Securities, 12 Months or Less - Unrealized Losses	420	60
Debt Securities, More than 12 Months - Unrealized Losses	72	67
Debt Securities - Total Unrealized Losses	492	127
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	975	5,487
Debt Securities - Total Fair Value	975	5,487
Debt Securities, 12 Months or Less - Unrealized Losses	25	13
Debt Securities - Total Unrealized Losses	$ 25	$ 13

XML

Loans Receivable and Allowance for Loan Losses (Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2021 USD ($) loan	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans, interest income lost	$ 343,000		$ 1,500,000
Loans Receivable >90 Days and Accruing	0		333,000
Loans acquired with deteriorated credit quality, fair value	884,000		1,100,000
Troubled debt restructurings, subsequent default, amount	$ 127,449	$ 0
Troubled debt restructuring, subsequent default, number | loan	1
Past due loans	$ 31,062,000		30,879,000
Less Than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past due loans	$ 7,300,000		$ 11,900,000

XML

Loans Receivable and Allowance for Loan Losses (Recorded Investment in Loans Receivable) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,333,263	$ 2,330,018	$ 2,190,677
Deferred loan fees, net	(1,352)	(1,358)
Allowance for loan losses	(35,477)	(33,639)
Sub-total	(36,829)	(34,997)
Net Loans	2,296,434	2,295,021
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369	268,137
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836	1,577,816
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967	101,692
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357	177,146
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667	64,857
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 851	$ 822	$ 1,029

XML

Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	$ 33,639	$ 23,734
Allowance for loan losses: Charge-offs	(57)	(4)
Allowance for loan losses: Recovery	30	304
Allowance for loan losses: Provisions	1,865	1,500
Allowance for loan losses: Ending balance: individually evaluated for impairment	5,307	3,232	$ 4,461
Allowance for loan losses: Ending balance: collectively evaluated for impairment	30,170	22,302	29,178
Allowance for loan losses: Ending Balance	35,477	25,534
Loans receivables: Ending balance: individually evaluated for impairment	67,344	23,022	83,201
Loans receivables: Ending balance: collectively evaluated for impairment	2,265,919	2,167,655	2,246,817
Loans receivables: Ending balance	2,333,263	2,190,677	2,330,018
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	3,293	2,722
Allowance for loan losses: Charge-offs	(57)	(4)
Allowance for loan losses: Recovery	27
Allowance for loan losses: Provisions	(426)	413
Allowance for loan losses: Ending balance: individually evaluated for impairment	302	354	416
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,535	2,777	2,877
Allowance for loan losses: Ending Balance	2,837	3,131
Loans receivables: Ending balance: individually evaluated for impairment	5,509	8,335	7,281
Loans receivables: Ending balance: collectively evaluated for impairment	228,866	259,802	237,088
Loans receivables: Ending balance	234,375	268,137	244,369
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	21,772	15,372
Allowance for loan losses: Provisions	1,347	(423)
Allowance for loan losses: Ending balance: individually evaluated for impairment	381	332	378
Allowance for loan losses: Ending balance: collectively evaluated for impairment	22,738	14,617	21,394
Allowance for loan losses: Ending Balance	23,119	14,949
Loans receivables: Ending balance: individually evaluated for impairment	44,086	9,895	61,854
Loans receivables: Ending balance: collectively evaluated for impairment	1,656,027	1,567,921	1,628,982
Loans receivables: Ending balance	1,700,113	1,577,816	1,690,836
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	1,977	1,244
Allowance for loan losses: Provisions	25	(139)
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,002	1,105	1,977
Allowance for loan losses: Ending Balance	2,002	1,105
Loans receivables: Ending balance: individually evaluated for impairment	2,787
Loans receivables: Ending balance: collectively evaluated for impairment	164,437	101,692	155,967
Loans receivables: Ending balance	167,224	101,692	155,967
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	6,306	3,790
Allowance for loan losses: Recovery		302
Allowance for loan losses: Provisions	275	(135)
Allowance for loan losses: Ending balance: individually evaluated for impairment	4,601	2,524	3,640
Allowance for loan losses: Ending balance: collectively evaluated for impairment	1,980	1,433	2,666
Allowance for loan losses: Ending Balance	6,581	3,957
Loans receivables: Ending balance: individually evaluated for impairment	13,269	3,466	12,492
Loans receivables: Ending balance: collectively evaluated for impairment	164,071	173,680	171,865
Loans receivables: Ending balance	177,340	177,146	184,357
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	286	333
Allowance for loan losses: Recovery	3	2
Allowance for loan losses: Provisions	4	290
Allowance for loan losses: Ending balance: individually evaluated for impairment	23	22	27
Allowance for loan losses: Ending balance: collectively evaluated for impairment	270	603	259
Allowance for loan losses: Ending Balance	293	625
Loans receivables: Ending balance: individually evaluated for impairment	1,693	1,326	1,574
Loans receivables: Ending balance: collectively evaluated for impairment	51,667	63,531	52,093
Loans receivables: Ending balance	53,360	64,857	53,667
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Provisions		5
Allowance for loan losses: Ending balance: collectively evaluated for impairment		5
Allowance for loan losses: Ending Balance		5
Loans receivables: Ending balance: collectively evaluated for impairment	851	1,029	822
Loans receivables: Ending balance	851	1,029	822
Unallocated [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	5	273
Allowance for loan losses: Provisions	640	1,489
Allowance for loan losses: Ending balance: collectively evaluated for impairment	645	1,762	$ 5
Allowance for loan losses: Ending Balance	$ 645	$ 1,762

XML

Loans Receivable and Allowance for Loan Losses (Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	$ 56,172	$ 17,839
Average Recorded Investment - With an allowance recorded	19,104	7,132
Average Recorded Investment - Total	75,276	24,971
Interest Income Recognized - With no related allowance recorded	375	203
Interest Income Recognized - With an allowance recorded	256	68
Interest Income Recognized - Total	631	271
Recorded Investment - With no related allowance recorded	43,731		$ 68,610
Recorded Investment - With an allowance recorded	23,613		14,591
Recorded Investment - Total	67,344		83,201
Unpaid Principal Balance - With no related allowance recorded	53,601		82,212
Unpaid Principal Balance - With an allowance recorded	39,394		20,722
Unpaid Principal Balance - Total	92,995		102,934
Related Allowance	5,307		4,461
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	3,453	4,656
Average Recorded Investment - With an allowance recorded	2,943	3,741
Interest Income Recognized - With no related allowance recorded	34	52
Interest Income Recognized - With an allowance recorded	32	41
Recorded Investment - With no related allowance recorded	2,821		4,084
Recorded Investment - With an allowance recorded	2,688		3,197
Unpaid Principal Balance - With no related allowance recorded	3,210		4,660
Unpaid Principal Balance - With an allowance recorded	2,723		3,252
Related Allowance	302		416
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	44,958	10,322
Average Recorded Investment - With an allowance recorded	8,013	1,241
Interest Income Recognized - With no related allowance recorded	282	99
Interest Income Recognized - With an allowance recorded	129	20
Recorded Investment - With no related allowance recorded	32,357		57,558
Recorded Investment - With an allowance recorded	11,729		4,296
Unpaid Principal Balance - With no related allowance recorded	33,761		58,739
Unpaid Principal Balance - With an allowance recorded	15,584		4,501
Related Allowance	381		378
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	1,394
Interest Income Recognized - With no related allowance recorded	36
Recorded Investment - With no related allowance recorded	2,787
Unpaid Principal Balance - With no related allowance recorded	2,787
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	5,171	2,013
Average Recorded Investment - With an allowance recorded	7,710	1,690
Interest Income Recognized - With no related allowance recorded	13	43
Interest Income Recognized - With an allowance recorded	93	3
Recorded Investment - With no related allowance recorded	4,498		5,844
Recorded Investment - With an allowance recorded	8,771		6,648
Unpaid Principal Balance - With no related allowance recorded	12,573		17,687
Unpaid Principal Balance - With an allowance recorded	20,662		12,511
Related Allowance	4,601		3,640
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	1,196	848
Average Recorded Investment - With an allowance recorded	438	460
Interest Income Recognized - With no related allowance recorded	10	9
Interest Income Recognized - With an allowance recorded	2	$ 4
Recorded Investment - With no related allowance recorded	1,268		1,124
Recorded Investment - With an allowance recorded	425		450
Unpaid Principal Balance - With no related allowance recorded	1,270		1,126
Unpaid Principal Balance - With an allowance recorded	425		458
Related Allowance	$ 23		$ 27

XML

Loans Receivable and Allowance for Loan Losses (Delinquency Status of Total Loans) (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	$ 31,062,000	$ 30,879,000
Current	2,302,201,000	2,299,139,000
Financing Receivable, Net, Total	2,333,263,000	2,330,018,000
Loans Receivable >90 Days and Accruing	0	333,000
30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	17,563,000	20,847,000
60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	5,602,000	4,178,000
Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	7,897,000	5,854,000
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	1,163,000	1,437,000
Current	233,212,000	242,932,000
Financing Receivable, Net, Total	234,375,000	244,369,000
Loans Receivable >90 Days and Accruing		125,000
Originated loans [Member] | Residential [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	936,000	507,000
Originated loans [Member] | Residential [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due		266,000
Originated loans [Member] | Residential [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	227,000	664,000
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	20,005,000	20,240,000
Current	1,680,108,000	1,670,596,000
Financing Receivable, Net, Total	1,700,113,000	1,690,836,000
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Commercial & Multi-family [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	13,148,000	15,910,000
Originated loans [Member] | Commercial & Multi-family [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	4,410,000	2,996,000
Originated loans [Member] | Commercial & Multi-family [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,447,000	1,334,000
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,787,000
Current	164,437,000	155,967,000
Financing Receivable, Net, Total	167,224,000	155,967,000
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Construction [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	2,787,000
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	6,406,000	8,147,000
Current	170,934,000	176,210,000
Financing Receivable, Net, Total	177,340,000	184,357,000
Loans Receivable >90 Days and Accruing		133,000
Originated loans [Member] | Commercial Business [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	457,000	3,889,000
Originated loans [Member] | Commercial Business [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	1,153,000	904,000
Originated loans [Member] | Commercial Business [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	4,796,000	3,354,000
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	701,000	1,055,000
Current	52,659,000	52,612,000
Financing Receivable, Net, Total	53,360,000	53,667,000
Loans Receivable >90 Days and Accruing		75,000
Originated loans [Member] | Home Equity [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	235,000	541,000
Originated loans [Member] | Home Equity [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	39,000	12,000
Originated loans [Member] | Home Equity [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Past Due	427,000	502,000
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current	851,000	822,000
Financing Receivable, Net, Total	851,000	822,000
Loans Receivable >90 Days and Accruing

XML

Loans Receivable and Allowance for Loan Losses (Troubled Debt Restructurings) (Details)	3 Months Ended
	Mar. 31, 2021 USD ($) loan	Mar. 31, 2020 USD ($) loan	Dec. 31, 2020 USD ($)
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 14,548,000		$ 16,063,000
Number of Contracts | loan	1	1
Post-Modification Outstanding Recorded Investments	$ 96,532	$ 216,102
Performing Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	13,474,000		13,760,000
Nonperforming Financing Receivable [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 1,074,000		$ 2,303,000

XML

Loans Receivable and Allowance for Loan Losses (Non-Accruing Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 14,405	$ 16,396
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	701	1,736
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	7,962	8,721
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	5,307	5,383
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 435	$ 556

XML

Loans Receivable and Allowance for Loan Losses (Loan Portfolio by Pass Rating) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,333,263	$ 2,330,018	$ 2,190,677
Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,235,899	2,256,702
Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	41,186	4,736
Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	56,178	68,580
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369	268,137
Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836	1,577,816
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967	101,692
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357	177,146
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667	64,857
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	851	822	$ 1,029
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	234,375	244,369
Originated loans [Member] | Residential [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	232,669	241,237
Originated loans [Member] | Residential [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	724	1,087
Originated loans [Member] | Residential [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	982	2,045
Originated loans [Member] | Commercial & Multi-family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,700,113	1,690,836
Originated loans [Member] | Commercial & Multi-family [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,622,917	1,631,838
Originated loans [Member] | Commercial & Multi-family [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	38,464	2,152
Originated loans [Member] | Commercial & Multi-family [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	38,732	56,846
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	167,224	155,967
Originated loans [Member] | Construction [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	164,437	155,967
Originated loans [Member] | Construction [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,787
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	177,340	184,357
Originated loans [Member] | Commercial Business [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	162,408	173,833
Originated loans [Member] | Commercial Business [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	1,998	1,497
Originated loans [Member] | Commercial Business [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	12,934	9,027
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	53,360	53,667
Originated loans [Member] | Home Equity [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	52,617	53,005
Originated loans [Member] | Home Equity [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	743	662
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	851	822
Originated loans [Member] | Consumer [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 851	$ 822

XML

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended		12 Months Ended
	Dec. 15, 2020	Sep. 01, 2020	Aug. 31, 2020	Aug. 10, 2020	Jul. 13, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Stockholders' Equity Note [Line Items]
Preferred stock redeemed, value							$ 140
Series H Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate	3.50%	3.50%			3.50%	3.50%	3.50%	3.50%
Proceeds from issuance of private placement	$ 2,250	$ 5,900			$ 3,100
Shares issued	225	590			308
Series F Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate			6.00%				6.00%
Preferred stock redeemed, shares			6,465
Preferred stock, redemption price			$ 1,000
Preferred stock redeemed, value			$ 6,500
Series C Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate				6.00%			6.00%
Preferred stock redeemed, shares				388
Preferred stock, redemption price				$ 10,000
Preferred stock redeemed, value				$ 3,900
Series G Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate						6.00%	6.00%	6.00%

XML

Bank Owned Life Insurance (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Jan. 31, 2021	Aug. 31, 2020	Mar. 31, 2021
Bank Owned Life Insurance [Abstract]
Bank owned life insurance, amount			$ 70,200
Bank owned life insurance, amount purchased	$ 8,500	$ 60,000
Bank-owned Life Insurance ("BOLI") income			$ 701

XML

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Impairment of intangible assets	$ 0
Goodwill	$ 5,200,000	$ 5,200,000
Core Deposit Intangibles [Member]
Intangible asset, useful life	10 years
Amortization expense	$ 16,000	18,000
Intangible assets, net	$ 219,000	$ 281,000

XML

Fair Values of Financial Instruments (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between fair value hierarchy	$ 0	$ 0
Impaired loans	23,613,000		$ 14,591,000
Valuation allowance	5,307,000		4,461,000
Significant Unobservable Inputs (Level 3) [Member] | Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	23,600,000		14,600,000
Valuation allowance	$ 5,300,000		$ 4,400,000

XML

Fair Values of Financial Instruments (Fair Value Measurements, Recurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	$ 93,582	$ 99,756
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Marketable Equities	18,278	17,717
Total Securities	111,860	117,473
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Equities	18,278	17,717
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities	18,278	17,717
Total Securities	18,278	17,717
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	93,582	99,756
Total Securities	93,582	99,756
Significant Unobservable Inputs (Level 3) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities
Total Securities

XML

Fair Values of Financial Instruments (Fair Value Measurements, Nonrecurring) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 18,306	$ 10,130
Other real estate owned	414	414
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	18,306	10,130
Other real estate owned	$ 414	$ 414

XML

Fair Values of Financial Instruments (Quantitative Information about Level 3 Fair Value Measurements) (Details) $ in Thousands	Mar. 31, 2021 USD ($) item	Dec. 31, 2020 USD ($) item
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	$ 18,306	$ 10,130
Other Real Estate Owned | $	414	414
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	18,306	10,130
Other Real Estate Owned | $	$ 414	$ 414
Significant Unobservable Inputs (Level 3) [Member] | Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	0	0
Other Real Estate Owned, Range | item	0	0
Significant Unobservable Inputs (Level 3) [Member] | Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	10	10
Other Real Estate Owned, Range | item	10	10

XML

Fair Values of Financial Instruments (Carrying Values and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available for sale	$ 93,582	$ 99,756
Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net	2,296,434	2,295,021
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Other Real Estate Owned	414
Deposits	2,404,135	2,318,050
Borrowings	133,298	191,161
Subordinated debentures	37,101	37,042
Accrued interest payable	807	1,463
Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Equity investments	18,278	17,717
Loans held for sale	1,147	3,530
Loans receivable, net	2,294,631	2,309,118
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Other Real Estate Owned	414
Deposits	2,408,469	2,323,561
Borrowings	131,806	194,899
Subordinated debentures	36,686	37,252
Accrued interest payable	807	1,463
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	296,938	261,229
Equity investments	18,278	17,717
Deposits	1,719,149	1,627,871
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest-earning time deposits	735	735
Debt securities available for sale	93,582	99,756
Loans held for sale	1,147	3,530
FHLB of New York stock, at cost	8,920	11,324
Accrued interest receivable	12,056	12,924
Deposits	689,320	695,690
Borrowings	131,806	194,899
Subordinated debentures	36,686	37,252
Accrued interest payable	807	1,463
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, net	2,294,631	$ 2,309,118
Other Real Estate Owned	$ 414

XML

Subordinated Debt (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Jul. 30, 2018
Trust Preferred Securities Subject to Mandatory Redemption [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.65%
Trust preferred securities	$ 4,124,000
Fixed To Floating Rate Subordinated Debentures [Member]
Subordinated Borrowing [Line Items]
Face amount			$ 33,500,000
Notes term	10 years
Redemption restriction period	5 years
Deferred finance costs	$ 523,000	$ 911,000
Fixed To Floating Rate Subordinated Debentures [Member] | First Five Years [Member]
Subordinated Borrowing [Line Items]
Interest rate	5.625%
Fixed To Floating Rate Subordinated Debentures [Member] | After Five Years [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.72%

XML

Lease Obligations (Narrative) (Details) - item	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Number of operating leases	28
Weighted average remaining lease term, operating leases	6 years 4 months 24 days	6 years 6 months 25 days
Weighted average discount rate, operating leases	2.65%	2.67%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	12 years

XML

Lease Obligations (Schedule of Lease Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Lease Obligations [Abstract]
Operating lease cost	$ 952	$ 854
Variable lease cost-operating leases	246	202
Operating lease right-of-use assets	14,328	14,988	$ 14,988
Current liabilities	3,020	2,992
Operating lease liabilities (noncurrent portion)	11,569	12,232
Total operating lease liabilities	$ 14,589	$ 15,224	$ 15,224

XML

Lease Obligations (Summary of Maturity of Lease Obligations for Operating Leases) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Lease Obligations [Abstract]
One year or less	$ 3,358	$ 3,348
Over one year through three years	5,225	5,424
Over three years through five years	3,269	3,459
Over five years	4,065	4,415
Gross Operating Lease Liabilities	15,917	16,646
Deferred Expenses	(1,328)	(1,422)
Total Operating Lease Liabilities	$ 14,589	$ 15,224	$ 15,224

XML

Subsequent Events (Narrative) (Details) - Subsequent Event [Member]	Apr. 14, 2021 $ / shares
Subsequent Event [Line Items]
Date declared	Apr. 14, 2021
Dividends per common share	$ 0.14
Date of record	May 10, 2021
Date paid	May 24, 2021